Education:    

1991             B.S. with honors Cornell University, Ithaca, New York

1995             M.D. with honors University of Rochester School of Medicine, Rochester, New York

2006             M.S., Division of Epidemiology and Biostatistics, University of Cincinnati

Post-Graduate Training:

Internship & Residencies

1995-1996    Resident in Psychiatry, Payne Whitney Clinic New York Hospital, Cornell Medical Center, New York, New York

1996-1998    Resident in Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio

Fellowships

1990             National Science Foundation Young Scientist Training Program

1991-1993    Fellow, MD/PhD Program, University of Rochester School of Medicine

1998-2000    Clinical Fellow, Child and Adolescent Psychiatry, Children’s Hospital Medical Center, Cincinnati, Ohio

1998-2000    Research Fellow, Bipolar and Psychotic Disorders Research Program, Department of Psychiatry, University of Cincinnati College of Medicine

Licensure:

1996             Ohio Medical License Registration, No. 35-07-1111

2000             American Board of Psychiatry and Neurology, No. 48470 

2001             American Board of Psychiatry and Neurology, Certification in Child and Adolescent Psychiatry, No. 5013

 

 

 

Academic Appointments:

7/2014-present Professor of Psychiatry and Pediatrics

                          Dr. Stanley & Mickey Kaplan Professor and Chair

                         Department of Psychiatry & Behavioral Neuroscience

                          University of Cincinnati College of Medicine

9/2010-present  Professor of Psychiatry, Pediatrics and Psychology, University of Cincinnati College of Medicine

9/2008-present  Tenure, Department of Psychiatry, University of Cincinnati College of Medicine

2007-2014        Vice-Chair of Clinical Research, Department of Psychiatry, University of Cincinnati College of Medicine

7/2005-present  Director, Research Training and Education, Division of Child Psychiatry, Cincinnati Children’s Hospital Medical Center

2004-present     Co-Director, Division of Bipolar Disorders Research, University of Cincinnati College of Medicine

2004- 2010       Associate Professor of Psychiatry, Pediatrics and Psychology University of Cincinnati College of Medicine

2002-2004        Associate Director, Bipolar and Psychotic Disorders Research Program, University of Cincinnati College of Medicine

2000-2004        Assistant Professor of Psychiatry and Pediatrics, University of Cincinnati College of Medicine

2000-2004        Director, Child and Adolescent Psychiatry Division, Psychotic and Bipolar Disorder Research Program, University of Cincinnati College of Medicine

Hospital Appointments:

1996-2001      Psychiatrist, Cincinnati VA, Cincinnati, Ohio        

1998-2000       Clinical Fellow in Child and Adolescent Psychiatry, University of    Cincinnati/Children’s Hospital Medical Center Cincinnati, Ohio

1998-present              Attending Psychiatrist University Hospital Cincinnati, Ohio

2000-present   Attending Psychiatrist Children’s Hospital Medical Center Cincinnati,   

                        Ohio

2013                Medical Director, Resident Mood Medication Clinic, University Hospital, Cincinnati, OH

Awards & Honors:

1987             Semi-finalist Westinghouse National Science Competition

1989-1991    Alpha Delta Epsilon Premedical Honor Society, Cornell University, Ithaca, NY

1991             Graduation from Cornell University with Honor and Distinction in All Subjects

1991             Gamma Sigma Delta Honor Society of Agriculture Science, Award for Outstanding Scholastic Achievement

1992-1993    Outstanding Academic Performance, University of Rochester School of Medicine

1993             Gilbert B. Forbes Prize in Pediatric Research, University of Rochester School of Medicine

1995             Graduation from University of Rochester School of Medicine with M.D. with honors

1996-1997    Honorable Mention, Resident Teaching Award, University of Cincinnati Department of Psychiatry

1997             Bayer Fellow, American Association of Geriatric Psychiatrists Annual Meeting, Orlando, Florida

1997             University of Cincinnati Representative, Wyeth-Ayerst American Psychiatric Association Resident Reporter Program

1997             University of Cincinnati Representative, Emory University School of Medicine’s Symposium, Advances in Mood Disorders and Schizophrenia

1998             Lilly Fellowship Award, Society of Biological Psychiatry

1998             Maurice Levine Essay Contest Award, Cincinnati Psychiatric Society; “Effects of family history of affective illness and substance abuse on substance abuse in first-episode bipolar patients”

1998             Young Investigators Research Colloquium, American Psychiatric Association

1998             Resident Research Award, Department of Psychiatry, University of Cincinnati College of Medicine

1998             Alpha Omega Alpha Medical Honor Society, University of Cincinnati College of Medicine

1999             Laughlin Fellow, American College of Psychiatry

1999             Lilly Fellowship Honorable Mention, American Psychiatric Association

1999             Maurice Levine Essay Contest Award, Cincinnati Psychiatric Society; “MRI analysis of the cerebellum in bipolar disorder”

1999             Psychiatric Resident of the Year Program, Pfizer Pharmaceuticals Excellence in Psychiatry Award, Organon   

1999             Resident Paper Award Honorable Mention, Central Neuropsychiatric Association

2000             Young Investigators Research Colloquium, American Psychiatric Association

2000             Junior Investigator Travel Award, “Assessing the impact of childhood interventions on subsequent drug abuse”, NIDA and NIMH.

2000             Presidential Scholar Award, American Academy of Child and Adolescent Psychiatry

2000             Resident Research Award, Department of Psychiatry, University of Cincinnati College of Medicine

2001             Lilly Pilot Research Award, American Academy of Child and Adolescent Psychiatry

2001             Fellowship in Child and Adolescent Depression, Klingenstein Third Generation Foundation

                        2001             Bristol-Myers Squibb Travel Award, 2001 American College of Neuropsychopharmacology

2001             National Institute of Mental Health Travel Award, 2001 Pediatric Depression Consortium

2002             Robinson-Cunningham Award, American Academy of Child and Adolescent Psychiatry

2002             National Institute of Mental Health, Pediatric Loan Repayment Program

2004             National Institute of Mental Health, Pediatric Loan Repayment Program

2004             Outstanding Mentor Award, American Academy of Child and Adolescent Psychiatry

                       2004-           Best Doctors in America, Best Doctors, Inc.

                       2005             Klerman Award for Outstanding Clinical Research, National Alliance for Research on Schizophrenia and Depression (NARSAD)

                         2006-2010,   National Institute of Mental Health, Pediatric Loan Repayment Program

                         2008             Dr. Stanley Leonard Mental Health Lecture, Children’s Hospitals of Minnesota

2008, 2010,  Outstanding Mentor Award, American Academy of Child and

 2012, 2014   Adolescent Psychiatry

                                            

Major Committee Assignments:

National Committees

2002-2005    Committee on Research Training, American Psychiatric Association

2002-2003        Special Emphasis Panel, Loan Repayment Program, National Center for      Minority Health and Disparities

2004-2006    Child and Adolescent Committee, Ohio Psychiatric Association

                        2005, 2006   Ad-hoc reviewer, Adult Psychopathology and Disorders of Aging Study Section, National Institute of Health, BBBP IRG

                        2006-2012    Workgroup on Research, American Academy of Child and Adolescent Psychiatry

                        2006-2012    Program Committee, American Academy of Child and Adolescent Psychiatry

                        2006-2012    Chair, Institute Subcommittee, Program Committee, American Academy of Child and Adolescent Psychiatry

                        2007             Ad-hoc reviewer, Special Emphasis Panel, National Institute of Mental Health, Refining and Testing Mental Health Interventions and Services for Youth with Mental Illness who are Transitioning to Adulthood

                2008-    Reviewer, Eli Lilly Pilot Research Award, American Academy of Child and Adolescent Psychiatry

2008-2009 Ad Hoc reviewer, Neural Basis of Psychopathology, Addictions and Sleep Disorders (NPAS) Study Section, National Institute of Health 

2009- 2012   Member, Neural Basis of Psychopathology, Addictions and Sleep Disorders (NPAS) Study Section, National Institute of Health 

2011-2103    Member, Publications Committee, American College of Neuropsychopharmacology

2012-            Chair, Research Committee, American Academy of Child and Adolescent Psychiatry

2012-2014    Chair, Neural Basis of Psychopathology, Addictions and Sleep Disorders (NPAS) Study Section, National Institute of Health 

2013-            Program Committee, Society of Biological Psychiatry

2014-            Program Committee, American College of Neuropsychopharmacology

                

University of Rochester School of Medicine

1993-1995    Pediatric Academic Advisory Committee

(Review and improve pediatric curriculum for medical students)

1992-1993    Chair, Medical Student Hosting Program Committee

(Host and review medical school applicant visits)

1993-1995    Medical Student Applicant Interviewer

University of Cincinnati Department of Psychiatry

1997-1998    Co-President, Residency Council

(Liaison between residents and faculty in Department of Psychiatry)

1997-1998    Residency Training Committee

(Review and improve curriculum, ongoing advisory board to Residency Director)

1997-2000    Resident Representative, Research Committee

(Enhance research in department)

1998-2000    Resident Representative, Grand Rounds Committee

(Coordinate and design grand rounds schedule)

2000-            Grand Rounds Committee

2004-2006    Appointments and Promotions Committee

2007-            Executive Committee

2009-           Appointments and Promotions Committee

University of Cincinnati College of Medicine

2000-2005    College of Medicine Admissions Committee

Children’s Hospital Medical Center Division of Child and Adolescent Psychiatry

2000-2007    Chair, Grand Rounds Committee

 

Other Professional and Research Experiences:

1985-1987    Research Intern, Montefiore Medical Center, Department of Molecular Oncology, Bronx, New York, “Differential expression of DNA in colonic tumors” Mentor: Leonard Augenlicht, Ph.D., Department of Oncology, Albert Einstein Cancer Center, Montifiore Hospital, Bronx, NY 10467

1988- 1991   Research Intern, Cornell University, Department of Molecular Biology and Genetics, Ithaca, New York, “Structure and function of Drosophila male accessory gland protein transcripts” Mentor: Mariana Wolfner, Ph.D., Department of Molecular Biology and Genetics, Cornell University Ithaca, NY 14853

1992-1994    Research Fellow, University of Rochester School of Medicine, Department of Pediatrics, Rochester, New York, “X-chromosome aberrations and states of activation in human breast tumors” Mentor: Nancy Wang, Ph.D., Department of Pediatrics, University of Rochester School of Medicine, Rochester, NY, 14642

1994-1996    Reviewer, medical education literature, F.A. Davis Publishing Company

1998             Cognitive Behavioral Therapy Training Workshop, John March, MD, MPH, Cincinnati, Ohio

1998             Kiddie-Schedule for Affective Disorders and Schizophrenia training, Barbara Geller, MD, St. Louis, Missouri

1999-            Journal Reviewer for Bipolar Disord, Biol Psychiatry, J Am Acad Child Adolesc Psychiatry, Arch Gen Psychiatry, J Child Adolesc Psychopharm, J Nat Med Assoc, Am J Psychiatry, Schizophr Res, J Clin Psychiatry, Neuropsychopharmacology, J Affect Disord

2002-            Professional Advisory Board, Child and Adolescent Bipolar Foundation

2002             “Bipolar Disorder Not Otherwise Specified Research Roundtable”, National Institute of Mental Health

2002             “Methodological Issues and Controversies in Clinical Trials with Child and Adolescent Patients with Bipolar Disorder”, working conference, American Academy of Child and Adolescent Psychiatry, work group leader

2003-            Editorial Board, J Clin Psychiatry (-2007), J Child Adolesc Psychopharmacol, Journal of Bipolar Disorders (-2012), Current Psychiatry (-2013), Depression and Anxiety (2008-2014).

2004-2010    Professional Advisory Board, Ohio Chapter of Depression and Bipolar Support Alliance

2004-2006    Steering Committee, Modeling Effective Antipsychotic Therapeutic Success by Utilizing Real Evidence (MEASURE) Continue Medical Education Programs

2004-            Scientific Advisory Board, Step Up for BP Kids

2005-            Editorial Board, Bipolar Disord

2005             Guest Editor, Bipolar Disord

2006-2007    Section Editor, Focus on Childhood and Adolescent Mental Health, J Clin Psychiatry

2006, 2010   Co-Chair, 31st Annual Review Course in Child and Adolescent Psychiatry, American Academy of Child and Adolescent Psychiatry, March 1-4, 2006 and April 21-24, 2010, Cincinnati, OH

2007-2008    Deputy Editor, J Clin Psychiatry

2007-            Section Editor for Child and Adolescent Psychiatry, Bipolar Disorders

2009             “Diagnostic classification of pediatric bipolar disorder”, National Institute of Mental Health Roundtable.  

2012-            Editorial Board, J Am Acad Child Adolesc Psychiatry

 

Professional Societies:

1991-1997    American Medical Association

1994-            American Psychiatric Association

1996-            Ohio Psychiatric Association, Cincinnati Chapter

1997-            American Association of Child and Adolescent Psychiatry 

1998-2000    American Neuropsychiatric Association

2000-2005   Society of Biological Psychiatry

2003-2009   Associate Member, American College of Neuropsychopharmacology

2006-           International Society for Bipolar Disorder

2010-           Member, American College of Neuropsychopharmacology

Principal Clinical & Hospital Service Responsibilities:

1996-2001    Staff Psychiatrist, Cincinnati VA Cincinnati, Ohio

1998-2000    Child and Adolescent Psychiatry Fellow, Children’s Hospital Medical Center, Cincinnati, Ohio

1999-2001    Attending Psychiatrist, Psychiatric Emergency Services, University Hospital, Cincinnati, Ohio

2000-            Attending Psychiatrist, Children’s Hospital Medical Center

Co-Director, Mood Disorders Program, Children’s Hospital Medical Center

Student Supervision:

1995-1996    Supervision of medical students in inpatient, outpatient, and emergency psychiatry, New York Hospital, Payne Whitney Clinic

1996-1998    Supervision of medical students in inpatient, outpatient, and   emergency adult psychiatry, University of Cincinnati College of Medicine

1998-1999    Supervision of Miami University summer students, University of Cincinnati COM

1998-            Supervision of medical students and residents in inpatient, outpatient, and emergency child & adolescent psychiatry, Children’s Hospital Medical Center

1999-2003    Supervision of Stanley Foundation Summer Medical Students, University of Cincinnati COM

2000-            Supervision of medical students, residents, psychology graduate students and child & adolescent psychiatry fellows in Mood Disorders Clinic, Children’s Hospital Medical Center

2001-            Psychology graduate student placement in pediatric mood disorders (20 hours), University of Cincinnati College of Medicine

2003-            Child and Adolescent Psychiatry Fellow Research Supervisor, Cincinnati Children’s Hospital Medical Center

2004-2005    Child and Adolescent Psychiatry Fellowship Rotation Supervisor, University of Barcelona Child and Adolescent Psychiatry Fellow

2009-2012    Research Observation Service and Education Program Supervisor,

                     University of Cincinnati College of Medicine

2011             Physician Scientist Training Program, Supervisor, University of Cincinnati College of Medicine

2010-2011    Child and Adolescent Psychiatry Fellowship Rotation Supervisor,

                     Instituto Nacional de Psiquiatria Ramon de la Fuente Child and Adolesent Psychiatry Fellow

 

Graduate Student Committees:

2002-2005   Juliet Warner, Ph.D., Psychology

2002-2004   Amy Jak, Ph.D., Psychology

2002-2004   Molly Zimmerman, Ph.D., Psychology

2003-2005   Mary Foster, M.S., Psychology

2005-2008   Elizabeth Gernert, M.S., Psychology

2007-2009   Jane Allendorfer, M.S., Neuroscience

2008-2012   Elizabeth Gernert, Ph.D., Psychology

2009-2012   Joaquin Burciaga, M.S., Psychology

2010-           Marguerite Reid, B.A., Neuroscience (Primary Mentor)

 

Teaching Experience:

1993-1995    Tutor for medical student courses in genetics, biochemistry and microbiology, University of Rochester, Rochester, NY

1996             Seminar for Child & Adolescent Psychiatry Fellowship, “Neuroimaging in children and adolescents with psychiatric disorders”, Children’s Hospital Medical Center, Cincinnati, OH

1997             Co- leader in psychoeducational group (20 weeks) for patients with schizophrenia and bipolar disorder, Central Psychiatric Clinic, Cincinnati, Ohio

1997             Seminar for Psychiatry Residents and Fellows, “Residency education.” University of Cincinnati COM, Cincinnati, OH

1998             Seminar for Child & Adolescent Psychiatry Fellows and 2nd year Psychiatry Residents, “Epidemiology of childhood psychiatric disorders” Children’s Hospital Medical Center, Cincinnati, OH

1999             Lecturer in Forensic Psychiatry Fellowship didactics, “Neuroimaging of sex offenders” University of Cincinnati COM, Cincinnati, OH.

1999             Seminar for Child & Adolescent Fellowship and 2nd year Psychiatry Residents, “Are stimulants over-prescribed?” Children’s Hospital Medical Center, Cincinnati, OH

1999             Lecturer for Adolescent Medicine Fellowship, “Research” didactics “Body dysmorphic disorder” Children’s Hospital Medical Center, Cincinnati, OH

2000-2002    Lecturer 2nd year Psychiatry Residents “Psychopharmacology” class “Attention deficit hyperactivity disorder: diagnosis and co-morbidity” & “Psychopharmacologic treatment of ADHD” University of Cincinnati COM, Cincinnati, OH

2000-2002    Lecturer for Child & Adolescent Psychiatry Fellowship “Cultural diversity” class, “Psychiatric diagnoses and the Jewish tradition” Children’s Hospital Medical Center, Cincinnati, OH

2000-            Lecturer in 2nd year Medical Student “Biobehavioral processes class, “An overview of child and adolescent psychopathology” University of Cincinnati COM, Cincinnati, OH

2000-2002    Lecturer in “Psychiatry Residency Research Training” class “Rating instruments” & “Presenting your research findings”, University of Cincinnati COM, Cincinnati, OH

2001-2003        Lecturer for 3rd and 4th year Psychiatry Residents, “General topics” class, “Childhood mood disorders”, University of Cincinnati COM, Cincinnati, OH

2002             Seminar for Psychology Graduate Students “Diagnosis of pediatric bipolar disorder”

2004, 2006   Lecturer in “Psychiatry Residency Research Training” class “Conducting Research Studies” “Introduction to Statistics-Parts 1  & 2”, University of Cincinnati COM, Cincinnati, OH

2006-2012    Lecturer for Child & Adolescent Psychiatry Fellowship, Advanced Psychopharmacology class, “Antipsychotic use in children and adolescents”, “Mood stabilizers in children and adolescents”, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

2006             Lecturer for Child & Adolescent Psychiatry Fellowship, Research Methods class, “Meta-analysis”, “Study design”

2009-           Course Organizer and Lecturer for 2nd year Residents in “Evidence-Based Psychiatry” class, “Applying evidence based psychiatry to practice”, “Systematic reviews and meta-analyses”, “Course overview & scholarly projects”, and “Outcome studies & studies of prognosis”.

2010-            Lecturer for Child & Adolescent Psychiatry Fellowship, Advanced Psychopharmacology class, “Pharmacological treatment of bipolar disorder”, Cincinnati Children’s Hospital Medical Center

2012-            Lecturer for Child & Adolescent Psychiatry Fellowship, 4 lecture series, “Bipolar Disorder in Youth”

 

 

Invited CME Lectures/Grand Rounds:

1998

“Effects of family history of affective illness and substance abuse on substance abuse in first-episode bipolar patients.” Cincinnati Psychiatric Society, Cincinnati, Ohio

“MRI analysis of the cerebellum in bipolar disorder.” APA Research Colloquium for Junior Investigators. Toronto, Canada.

“Use of MRI in psychiatry” Volunteers of America, New Life Program, Cincinnati, Ohio

1999

“MRI analysis of the cerebellum in bipolar disorder” Maurice Levine Award Lecture, Cincinnati Psychiatric Society, Cincinnati, Ohio

“Children at high risk for bipolar disorder” Bipolar Disorder Support Group, Cincinnati, Ohio

“Head injury in sexual offenders: a neurobiological prospective” Sexual Offenders- Providing Preventative Treatment Conference, Cincinnati, Ohio

“Children at risk for bipolar disorder” NIMH workshop, “Early recognition and treatment of children with schizophrenia and bipolar disorder”, Washington, DC

2000

“Effects of family history of affective illness and substance abuse on substance abuse in first-episode bipolar patients” APA Research Colloquium for Junior Investigators. Chicago, IL

“Childhood psychotic and mood disorders” Mental Health Association of Cincinnati, Cincinnati, OH

“Treatment of bipolar disorder”, Western Kansas City Psychiatric Society, Kansas City, MO “Neuropsychiatry of bipolar disorder”, Department of Psychiatry St. Francis Hospital, Pittsburgh, PA

“Careers in psychiatry”, Ohio State Medical School, Columbus, OH

“The evaluation and treatment of bipolar and co-occurring disorder”, Dayton VA, Dayton, OH

2001

“Treatment of pediatric bipolar disorder”, Janssen Preceptorship in Bipolar Disorders

“Treatment of childhood mood and psychotic disorders”, Midwestern Louisiana Psychiatric Society, Shreveport, LA

“Diagnosis of pediatric bipolar and comorbid disorders”, Louisiana State University, Shreveport, LA

“Psychopharmacological treatment of pediatric bipolar disorder”, Virginia Beach Medical Society, Virginia Beach, VA

“MRS in children at risk for bipolar disorder”, American Academy of Child and Adolescent Psychiatry Annual Meeting, Honolulu, HA

“Depression and anxiety disorders in children”, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

“Pharmacological treatment of pediatric depression”, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

“Treatment of bipolar mania”, Lexington Psychiatric Society, Lexington, KY

                                  

2002

“Pharmacological treatment of pediatric anxiety disorders”, Cincinnati/Dayton Child and Adolescent Psychiatric Society, Cincinnati, OH

“Diagnosis and treatment of pediatric bipolar disorder”, Columbus Child and Adolescent Psychiatric Society, Columbus, OH

“Neuroimaging of bipolar disorder, from childhood to adulthood”, Stanford University, Department of Psychiatry, Palo Alto, CA

 “Diagnosis and innovative treatments for bipolar disorder”, Hamilton Medical Society, Hamilton, OH

“Diagnosis and treatment of pediatric bipolar disorder”, University of Arizona at Tucson, Department of Psychiatry, Tucson, AZ

“Treatment of pediatric bipolar disorder”, West Virginia Medical Center, Charleston, West Virginia

“Diagnosis and treatment of childhood and adolescent bipolar disorder”, Schneider’s Children’s Hospital, Long Island Jewish Medical Center, New York, New York

“Neurodevelopment of bipolar disorder: Neuroimaging findings across the lifespan”, Ohio State University, Columbus, OH

“Atypical antipsychotics for the treatment of pediatric bipolar disorder”, American Academy of Child and Adolescent Psychiatry Annual Meeting, San Francisco, CA

“Novel treatments for pediatric bipolar disorder”, Central Ohio Psychiatric Society, Columbus, OH

“Diagnosis and treatment of pediatric bipolar disorder”, London Psychiatric Hospital, London, Ontario, CA

“Bipolar Disorder: Recognition and Management Across the Life Span”, PsychLINK

                                   2003

“Diagnosis and management of pediatric bipolar disorder”, Queen’s Children’s Psychiatric Hospital, Queens, New York

“Diagnosis and treatment of bipolar disorder”, Queen’s Hospital Department of Psychiatry, Queens, New York

“Management of bipolar disorder in children and adolescents”, St. Louis University, St. Louis, MO

“Neuropharmacology of pediatric bipolar disorder”, University of Illinois, Division of Child Psychiatry, Chicago, Illinois

“Phenomenology and neuropharmacology pediatric bipolar disorder”, Western Pennsylvania Psychiatric Society, Pittsburgh, PA

“Use of atypical antipsychotics for the treatment of acute mania”, San Juan VA, San Juan, Puerto Rico

“Phenomenology and treatment of bipolar disorder across the life span”, Ohio State University, Columbus, Ohio

The Neurophysiology of bipolar disorder: clues from neuroimaging: an overview of pediatric bipolar disorder”, Department of Internal Medicine, University of Cincinnati College of Medicine

“Pediatric and adult bipolar disorders: diagnostic issues and novel treatments”, Distance Learning Network.

“Pediatric bipolar disorder: phenomenology and treatment”, Division of Child Psychiatry, University of British Columbia, Vancouver, BC

“Management of adolescent mania”, American Psychiatric Association Annual Meeting, San Francisco, CA

“Psychopharmacology of pediatric bipolar disorder”, American Academy of Child and Adolescent Psychiatry Annual Meeting, Miami, FL

“Neuropharmacology of pediatric bipolar disorder” Colorado Regional Mental Health Association, Montrose, CO

“Phenomenology and treatment of pediatric bipolar disorder” Kingston Hospital, Ontario, CA

“Phenomenology and treatment of bipolar disorder across the lifespan”, London Psychiatric Hospital, London, Ontario, CA

“Novel treatments for pediatric bipolar disorder”, Canadian Academy of Child and Adolescent Psychiatry, Halifax, Nova Scotia

                                  

2004

“Neuropharmacology of bipolar disorder across the lifespan”, Duke University, North Carolina

“Phenomenology and treatment of bipolar disorder: novel perspectives”, University of Arkansas, Little Rock, Arkansas

“Role of atypical antipsychotics in treatment of pediatric psychotic disorders & common comorbidities, American Psychiatric Association Annual Meeting, New York, NY

“Bipolar disorder and its comorbidities: rational use of combination treatments”, Distance Learning Network

“Balancing the efficacy and tolerability of pharmacological treatment for children and adolescents with bipolar disorder”, American Psychiatric Association Annual Meeting, New York, NY

“Neuropharmacology of bipolar disorder: pediatric perspective”, New York University, New York, NY

“Phenomenology and treatment of pediatric bipolar disorder”, University of Utah, Salt Lake City, Utah

“Neuropharmacology of pediatric bipolar disorder”, University of Minnesota, Minneapolis, Minnesota

“Phenomenology and neurobiology of pediatric bipolar disorder”, University of Illinois, Chicago, Illinois

“Neuropharmacology of pediatric bipolar disorder”, Rush University Medical Center, Chicago, Illinois

“Bipolar disorder: approaches to earlier and more effective treatment”, University of Michigan, Detroit, Michigan

 “Neuropharmacology of pediatric bipolar disorder”, University of Washington, Seattle, Washington

“Pediatric bipolar disorder: An update on phenomenology, outcome, and treatment”, Vanderbilt University, Division of Child and Adolescent Psychiatry

“An update on the pharmacology of bipolar disorder in children and adolescents”, Children’s Resource Group, Indianapolis, Indiana

“Assessment of aggression in clinical trials”, 43th Annual New Clinical Drug Evaluation Unit Meeting, Phoenix, Arizona.                                

2005

“Neuropharmacology of pediatric bipolar disorder”, Medical University of South Carolina, Charleston, South Carolina

“Balancing efficacy and tolerability in pediatric bipolar disorder”, American Psychiatric Association Psychopharmacology Update, Las Vegas, Nevada.

“Novel treatments for pediatric bipolar disorder”, Children’s Resource Group, Indianapolis, Indiana

“Neuropharmacology of pediatric bipolar disorder”, University of New Mexico, Albuquerque, New Mexico

“Prodromal mood and psychotic disorders: Early recognition and intervention”, Distance Learning Network

Neuropharmacology of pediatric bipolar disorder”, North Star Behavioral Health System and the Pacific Northwest Regional Council of the American Academy of Child and Adolescent Psychiatry, Anchorage, Alaska

“Pediatric bipolar disorder: An update” Pediatric Update Series, Washington University in St. Louis School of Medicine, St. Louis, Missouri

“Phenomenology and treatment of pediatric bipolar disorder: An Update” American Society of Clinical Psychopharmacology Annual Meeting, New York, New York

                                  

2006

Treating mood disorders in a primary care setting”, Department of Family Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio

“Treatment of pediatric bipolar and psychotic disorders”, 31st Annual Review Course in Child and Adolescent Psychiatry, American Academy of Child and Adolescent Psychiatry, Cincinnati, Ohio

“Pediatric bipolar disorder: An update” Case Western Reserve, Division of Child and Adolescent Psychiatry, Cleveland, Ohio

“Neuropharmacology of bipolar disorder” Whitby Mental Health, Ontario, Canada

“Treatment of pediatric bipolar disorder” Child and Adolescent Psychiatric Society, Quebec City, Canada

“Neuropharmacology of pediatric bipolar disorder”, New York Psychiatric Institute, Department of Child and Adolescent Psychiatry, New York, New York

“Treatment of bipolar disorder across the lifespan” Oshawa Hospital, Oshawa, Ontario, Canada

“Bipolar disorder: An update on pharmacological treatment”, Laval University Hospital, Quebec, Canada

“Atypical antipsychotics in children and adolescents”, Distance Learning Network, New York, New York.

                                   2007

“Are there evidenced-based treatments for pediatric bipolar disorder?” Georgia Psychiatric Physicians Association, Ponte Verde, Florida.

“Neurobiology and psychopharmacology of childhood and adolescent bipolar disorder” Mental Health Professional Conference on Child & Youth/Teen Bipolar Disorder, Ohio State University, Columbus, Ohio

“Phenomenology and treatment of pediatric bipolar disorder: An update” Victoria Child and Adolescent Psychiatric Association, Victoria, Canada

“Neuropharmacology of adolescent bipolar disorder” Brown University/Bradley Hospital, Department of Child and Adolescent Psychiatry, Providence, Rhode Island

“Mood disorders in Women” Department of OB/GYN, University of Cincinnati, Cincinnati, OH

“Pharmacological treatment of youth with bipolar disorder: An update” 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston, Massachusetts

“Clinical and biological predictors of outcome in bipolar youth” 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Boston, Massachusetts

                                  

                                   2008

“Topiramate for cannabis use and bipolar disorders”, Medications Development for the Treatment of Cannabis Related Disorders, National Institute of Drug Abuse, Washington, DC

“Presentation and diagnosis of bipolar disorder in children and adolescents”, Bipolar Disorder in Children and Adolescents Assessment and Management, Child and Adolescent Mental Heath Care Program Annual Conference, Children’s Hospital of Western Ontario, London Health Sciences Centre, London, London, Ontario, Canada

“Neuropharmacology of adolescent bipolar disorder”, Indiana University School of Medicine, Indianapolis, Indiana

“Pharmacological treatment of bipolar disorder in children and adolescents”, Bipolar Disorder in Children and Adolescents Assessment and Management, Child and Adolescent Mental Heath Care Program Annual Conference, Children’s Hospital of Western Ontario, London Health Sciences Centre, London, London, Ontario, Canada

“Neuropharmacology of adolescent bipolar disorder”, University of Arizona, Tucson, AZ

“The ups, downs, and in betweens of bipolar disorder”, Children's Hospitals and Clinics of Minnesota, St. Paul, Minnesota

“Treatment of bipolar disorder in children and adolescents” (Dr. Stanley Leonard Pediatric Mental Health Lecture), Children's Hospitals and Clinics of Minnesota, St. Paul, Minnesota

“Neuropharmacology of adolescent bipolar disorder”, University of Michigan, Ann Arbor, Michigan

 

                                   2009

“Neuroimaging of bipolar disorder in children and adolescents: New frontiers”, Texas Child and Adolescent Psychiatric Society Annual Meeting, Fort Worth, Texas

 “Advanced psychopharmacology for youth with bipolar disorder”, University of Navarra, Pamplona, Spain

“Treatment of mood disorders in youth”, 3rd National Congress of Turkish Association for Psychopharmacology, Istanbul, Turkey

“Research strategies in pediatric bipolar disorder” and “psychopharmacological management of pediatric bipolar disorder”, Department of Child and Adolescent Neuropsychiatry, National Health System, Rome, Italy

“A double-blind placebo-controlled study of quetiapine for youth with depression associated with  bipolar disorder”, NCDEU Annual Meeting, Hollywood, Florida

“Maintenance treatment for bipolar disorder”, Mississippi State Hospital, Jackson, Mississippi

“Diagnosis and neurobiology of children and adolescents with bipolar disorder”, McGill University, Montreal, Canada

“Neuropharmacology of adolescent bipolar disorder”, University of Texas at Southwestern, Dallas, Texas                               

                                                                        2010

“Children and adolescents with bipolar disorder: An update on research”, Department of Child and Adolescent Neuropsychiatry, National Health System, Rome, Italy

“Diagnosis and treatment of bipolar disorder in children and adolescents”, AACAP Board Review Course, Cincinnati, OH

Functional MRI and magnetic resonance spectroscopy (MRS) markers of treatment response and effects in adolescent mania”, NCDEU Annual Meeting, Hollywood, Florida.

“The neuropharmacology of Adolescent Bipolar Disorder”, University of Alabama, Birmingham, Alabama

                                   2011

“The neurodevelopment and neuropharmacology of bipolar disorder in youth”, University of Texas at Houston Psychiatry Grand Rounds, Houston, Texas

“Neurobiology and treatment of youth at risk for bipolar disorder: a window of opportunity”, The Zucker Hillside Hospital, Glen Oaks, New York

“Diagnosis and treatment of bipolar disorder in youth”, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio

                                                                       

                                                                        2012

“Bipolar disorder in youth: outcome and treatment”, Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, Ohio

Betty Simon Lecture: “Neuropsychopharmacology of adolescent bipolar disorder, University of Iowa

“Exploring the uncharted territory of research in child and adolescent psychiatry”, Taiwan Society of Child and Adolescent Psychiatry Annual Meeting, Taipei, Taiwan

“Bipolar disorder in youth: recent research advancements”, Taiwan Society of Child and Adolescent Psychiatry Annual Meeting, Taipei, Taiwan

“Findings of new-onset mania study”, Taipei Medical University Hospital, Taipei, Taiwan

“Epidemiology, clinical course, differential diagnosis and treatment response of child & adolescent bipolar disorder”, Korean Association of Child and Adolescent Psychiatry, Seoul, Korea

“What are the differences in clinical features of ADHD and child and adolescent bipolar disorder?” Korean Association of Child and Adolescent Psychiatry, Seoul, Korea

“An update of bipolar disorder in youth, Severance Children’s Hospital”, Yonsei University College, Seoul, Korea, Seoul National University Hospital Seoul, Korea, and Asan Medical Center Seoul, Korea

Bibliography:                                                      

Peer Reviewed Reports:

      1999

1.    Sax KW, Zimmerman ME, DelBello MP, Hawkins JM, Keck PE, Jr, Strakowski SM: Frontosubcortical neuroanatomy and the continuous performance test in mania.  Am J Psychiatry 156:139-141, 1999.

2.    Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM, Larson    ER: Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 56:254-260, 1999.

3.    DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW: MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology 21:63-69, 1999.

4.    Shapira NA, DelBello MP, Goldsmith TD, Rosenberger BM, Keck PE, Jr: Evaluation of   bipolar disorder in prelingual deaf inpatients. Am J Psychiatry 156:1267-1269, 1999.

5.    DelBello MP, Strakowski SM, Sax KW, McElroy SL, Keck PE, Jr, Kmetz GF: Familial rates of affective and substance use disorders in patients with first episode mania. J Affect Disord 56:55-60, 1999.

6.    DelBello MP, Soutullo CA, Zimmerman ME, Sax KW, McElroy SL, Strakowski SM: Traumatic brain injury in individuals convicted of sexual offenses with and without bipolar disorder.  Psychiatry Res 89:281-286, 1999.

       2000

7.    DelBello MP, Soutullo CA, Strakowski SM: Racial differences in the treatment of adolescents with bipolar disorder (letter).  Am J Psychiatry 157:837-838, 2000.

8.    Strakowski SM, Williams JR, Fleck DE, DelBello MP: Eight-month functional outcome from mania following a first psychiatric hospitalization. J Psychiatr Res 34:193-200, 2000.

9.    DelBello MP, Foster KD, Strakowski SM: Case Report: Treatment of catatonia in an adolescent male. J Adolesc Health 27:69-71, 2000.

10.  Strakowski SM, DelBello MP, Adler C, Cecil KM, Sax KW: Neuroimaging in bipolar disorder. Bipolar Disord 2:148-164, 2000.

11.  Strakowski SM, DelBello MP, Fleck DE, Arndt S: The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 48:477-485, 2000.

12.  Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, DelBello MP, Soutullo CA: Six month stability and outcome of a prepubertal and early adolescent bipolar disorder phenotype. J Child Adolesc Psychopharm 10:165-174, 2000.

13.  Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, DelBello MP, Soutullo CA: Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty, and comorbid ADHD. J Child Adolesc Psychopharmacol 10: 157-164, 2000.

14.  DelBello MP, Lopez-Larson MP, Getz GE, Strakowski SM: Treatment of schizoaffective disorder with divalproex sodium. Schizophr Res 46:77-79, 2000.

15.  Strakowski SM, Williams JR, Sax KW, Fleck DE, DelBello MP, Bourne ML: Is impaired outcome following a first manic episode due to mood-incongruent psychosis. J Affect Disord 61:87-94, 2000.

16.  Geller B, Bolhofner K, Craney JL, Williams M, DelBello MP, Gundersen K: Psychosocial functioning in a prepubertal and early adolescent bipolar phenotype. J Am Acad Child Adolesc Psychiatr, 39:1543-1548, 2000.

                       

      2001

17.  Geller B, Craney JL, Bolhofner K, DelBello MP, Williams M, Zimerman B: One-year recovery and relapse rates of a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 158:303-305, 2001.

18.  DelBello MP, Lopez-Larson MP, Soutullo CA, Strakowski SM: Effects of race on psychiatric diagnosis of hospitalized adolescents: a retrospective chart review. J Child Adolesc Psychopharmacol 11:95-103, 2001.

19.  Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, DelBello MP, Soutullo C: Reliability of the Washington University in St. Louis Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections, J Am Acad Child Adolesc Psychiatry 40:450-455, 2001.

20.  DelBello MP, Soutullo CA, Niemeier RT, Henricks WL, McElroy SL, Strakowski SM:  Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disord 3:53-57, 2001.

21.  Strakowski SM, Sax KW, Rosenberg HL, DelBello MP, Adler CM: Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance? Neuropsychopharmacology 25:548-554, 2001.

22.  DelBello MP, Geller B: Review of studies of child and adolescents offspring of bipolar parents. Bipolar Disord 3:325-334, 2001.

2002

23. Getz GE, DelBello MP, Fleck DE, Zimmerman ME, Schwiers M, Strakowski SM: Neuroanatomic characterization of schizoaffective disorder using MRI: A pilot study. Schizophr Res 1:55-59, 2002.

24. Strakowski SM, Adler CM, DelBello MP: Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? Bipolar Disord 4:80-88, 2002.

25. Geller B, Zimerman B, Williams M, DelBello MP, Frazier J, Beringer L: Phenomenology of prepubertal and early adolescent bipolar disorder: examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts and hypersexuality. J Child Adolesc Psychopharmacol 12:3-9, 2002.

26. Geller B, Zimerman B, Williams M, DelBello MP, Bolhfner K, Craney JL, Frazier J, Beringer L, Nickelsburg MJ: DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls.  J Child Adolesc Psychopharmacol 12:11-25, 2002.

27. McDonough-Ryan P, DelBello MP, Shear PK, Ris DM, Soutullo CA, Strakowski SM: Academic and cognitive abilities in children of parents with bipolar disorder: a test of the nonverbal learning disability model.  J Clin Exp Neuropsychol 24:280-285, 2002. 

28. Lopez-Larson MP, DelBello MP, Zimmerman ME, Schwiers ML, Strakowski SM: Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry 52:93-100, 2002.

29. Soutullo CA, DelBello MP, Ochsner JE, McElroy SL, Taylor SA, Strakowski SM, Keck PE:  Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J Affect Disord 70:323-327, 2002.

30. Fleck DE, Henricks WL, DelBello MP, Strakowski SM: Differential prescription of maintenance antipsychotics to African-American and white patients with new-onset bipolar disorder, J Clin Psychiatry 63:658-664, 2002.

31. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM: A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania associated with bipolar disorder. J Am Acad Child Adolesc Psychiatry 41:1216-1223.

32. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear PK, Adler CM: Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 159:1841-1847, 2002.

33. DelBello MP, Kowatch RA, Warner J, Schwiers ML, Rappaport KB, Daniels JP, Foster KD, Strakowski SM: Topiramate treatment for pediatric bipolar disorder: A retrospective chart review.  J Child Adolesc Psychopharmacol 12:323-330, 2002.

34. Cecil KM, DelBello MP, Morey R, Strakowski SM: Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 4:357-365, 2002.

35. Kowatch RA, DelBello MP, Findling RL: Depressive episodes in children and adolescents with bipolar disorders. Clinical Neurosci Res 2:158-160, 2002.

36.  Shear PK, DelBello MP, Rosenberg HL, Strakowski SM:  Parental reports of executive  dysfunction in manic adolescents with bipolar disorder. Child Neuropsychol 8:285-295, 2002.

                                     2003

37. Carlson GA, Jensen PS, Findling R, Meyer RE, Calabrese J, DelBello MP, Emslie G, Kusmakar V, Laughren T, Leibenluft E, McCracken J, Pine D, Sachs G, Shaffer D, Simar R, Strober M, Weller E, Wozniak J, Youngstrom E:  Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder.  J Child Adolesc Psychopharmacol, 13:13-27, 2003.

38.  Strakowski SM, DelBello MP, Adler CM, Keck Jr PE. Atypical antipsychotics in the treatment of bipolar disorder. Expert Opinion on Pharmacotherapy 2003;4:751-760.

39.  DelBello MP, Carlson G, Tohen M, Bromet E, Schwiers M, Strakowski SM: Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features.  J Child Adolesc Psychopharmacol 13:173-185, 2003.

40.  Tillman R, Geller B, Nickelsburg MJ, Bolhofner K, Craney JL, DelBello MP, Wigh W: Life events in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharmacol 13:243-252, 2003.

41.   Cecil KM, DelBello MP, Sellers MC, Strakowski SM: Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk from bipolar disorders. J Child Adolesc Psychopharmacol 13:545-555, 2003.

 

           2004

42. Fleck DE, DelBello MP, Zimmerman ME, Getz GE, Shear PK, Strakowski SM: Selective attention in schizoaffective disorder: pilot data.  Schizophr Res 68:109-110, 2004.

43. DelBello MP, Zimmerman ME, Mills NP, Getz GE, Strakowski SM: Magnetic resonance imaging analysis of amygdale and other subcortical brain regions in adolescents with bipolar disorder.  Bipolar Disord 6:43-52, 2004.

44. Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, Sachs GS, Nierenberg AA; STEP-BD Investigators: Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).  Biol Psychiatry 55:875-881, 2004.

45. Wilke M, Kowatch RA, DelBello MP, Mills NP, Holland SK: Voxel-based morphometry in adolescents with bipolar disorder.  Psychiatry Res: Neuroimag 131:57-69, 2004.

46. Barzman D, Gernert B, DelBello MP: Quetiapine for the treatment of tic disorder. Am J Psychiatry 161:1307, 2004.

47. DelBello MP, Adler CM, Strakowski SM: Divalproex for the treatment of aggression associated with adolescent mania. J Child Adolesc Psychopharmacol 14:325-328, 2004.

48. Strakowski SM, Adler CM, Holland SK, Mills NP, DelBello MP: A Preliminary fMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacol 29:1734-1740, 2004.

49. DelBello MP, Adler CM, Amicone J, Warner J, Shear PK, Mills N, Strakowski SM: Parametric neurocognitive task design: A pilot study of a task of sustained attention in adolescents with bipolar disorder.  J Affect Disord 82: Suppl 1:79-88, 2004.

50. Barzman D, DelBello MP, Kowatch RA, Gernert B, Fleck DE, Pathak S, Rappaport K, Delgado SV, Campbell P, Strakowski SM:  The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.  J Child Adolesc Psychopharmacol 14:593-600, 2004.     

51. DelBello MP, Strakowski SM.  Neurochemical predictors of response to pharmacological treatments for bipolar disorder.  Current Psychiatry Reported.  6:466-472, 2004.

                       

2005

52. Mills NP, DelBello MP, Adler CM, Strakowski SM: MRI analysis of cerebellar vermal abnormalities in bipolar disorder. Am J Psychiatry 162:1530-1532, 2005.

53. Adler CM, DelBello MP, Mills NP, Schmithorst V, Holland S, Strakowski SM: Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task. Bipolar Disord 7:577-588, 2005.

54. Patel NC, DelBello MP, Keck PE Jr, Strakowski SM:  Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder.  J Child Adolescent Psychopharmacol 15:938-946, 2005. 

55. Romero S, DelBello MP, Soutullo CA, Stanford K, Strakowski SM: family environment in families with versus families without parental bipolar disorder: a preliminary comparison study. Bipolar Disord 7:617-622, 2005.

56  Barzman DH, DelBello MP, Kowatch RA, Warner J, Rofey D, Stanford K, Rappaport K, Daniels JP, Strakowski SM. Adjunctive topiramate in hospitalized children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 15:931-937, 2005.

57 Kratochvil CJ, DelBello M, Upadhyaya H, Wozniak J: Pharmacological management of new-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:1198-2000, 2005.

58. Strakowski SM, DelBello MP, Adler CM: The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatr 10:105-116, 2005.

59. Swann AC, Geller B, Post RM, Altshuler L, Chang KD, DelBello MP, Reist C, Juster IA. Practical clues to early recognition of bipolar disorder: A primary care approach. Prim Care Companion J Clin Psychiatry 7:15-21, 2005.

60. Strakowski SM, Adler CM, Holland SK, Mills N, DelBello MP, Eliassen JC: Abnormal fMRI brain activation in euythymic bipolar disorder during a counting Stroop interference task. Am J Psychiatry 162:1697-1705.

61. Strakowski SM, DelBello MP, Fleck DE, Adler CM, Anthenelli RM, Keck PE Jr., Arnold LM, Amicone J: Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry 62:851-858, 2005.

62. Strakowski SM, Johnson JL, DelBello MP, Hamer RM, Green AI, Tohen M, Lieberman JA, Glick I, Patel JK, and the HGDH Research Group: Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. Schizophr Res 78:161-169, 2005.

63. DelBello MP, Findling RL, Kushner S, Wang D, Olson WH, Capece JA, Fazzio L, Rosenthal NR: Controlled trial of topiramate for mania in children and adolescents with bipolar disorder.  J Am Acad Child Adolesc Psychiatry 44:539-547, 2005.

64. Perlis RH, DelBello MP, Miyahara S, Wisniewski SR, Sachs GS, Nierenberg AA; STEP-BD investigators. Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants. Biol Psychiatry 58:549-553, 2005.

65. Adler CM, Levine AD, DelBello MP, Strakowski SM. Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry 58:151-157, 2005.

          

2006

66. Patel NC, DelBello MP, Strakowski SM: Ethnic differences in symptom presentation of youths with bipolar disorder. Bipolar Disord 8:95-99, 2006.

67. Patel NC, DelBello MP, Strakowski SM, Keck PE: Phenomenology associated with age at onset in patients with bipolar disorder at their first psychiatric hospitalization. Bipolar Disord 8:91-94, 2006.

68. Adler CM, Adams J, DelBello MP, Holland SK, Schmithorst V, Levine A, Jarvis K, Strakowski SM. Evidence of white matter pathology in first-episode manic adolescents with bipolar disorder: A diffusion tensor imaging study. Am J Psychiatry 163:322-324, 2006.

69. Patel NC, DelBello MP, Bryan HS, Adler CM, Stanford KE, Kowatch RA, Strakowski SM:  Open-label lithium for the treatment of adolescents with bipolar depression.  J Am Acad Child Adolescent Psychiatry 45:289-297, 2006.

70. DelBello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, Nelson E, Strakowski SM: A Double-blind pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolescent Psychiatry 45:305-313, 2006.

71. Barzman DH, DelBello MP. Topiramate for co-occurring bipolar disorder and disruptive behavior disorders. Am J Psychiatry 163: 1451-1452, 2006.

72. Patel NC, DelBello MP, Kowatch RA, Strakowski SM:  Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder.  J Child Adolesc Psychopharmacol 16:327-335, 2006.

73. Fleck DE, Arndt S, DelBello MP, Strakowski SM: Concurrent tracking of alcohol use and bipolar disorder symptoms. Bipolar Disord 8:338-344, 2006.

74. Zimmerman ME, DelBello MP, Getz GE, Shear PK, Strakowski SM: Anterior cingulate subregion volumes and executive function in bipolar disorder. Bipolar Disord 8:281-288, 2006.

75. Adler CM, DelBello MP, Strakowski SM: Brain network dysfunction in bipolar disorder. CNS Spectr 11:312-320, 2006.

76. DelBello MP, Adler CM, Strakowski SM: The neurophysiology of childhood and adolescent bipolar disorder. CNS Spectr 11:298-311, 2006.

77. Singh MK, DelBello MP, Soutullo CA, Stanford KE, McDonough-Ryan P, Strakowski SM: Obstetrical complications in children at high risk for bipolar disorder. J Psychiatr Res 41: 680-685, 2006.

78. DelBello MP, Kowatch RA: Pharmacological interventions for bipolar youth: Developmental considerations. Dev Psychopathol 18:1231-1246, 2006.

79. Patel NC, DelBello MP, Cecil KM, Adler CM, Bryan HS, Stanford KE, Strakowski SM: Lithium treatment effects on myo-inositol in adolescents with bipolar depression.  Biol Psychiatry 60:998-1004, 2006.

80. Singh MK, DelBello MP, Kowatch RA, Strakowski SM: Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children. Bipolar Disord 8:710-720, 2006.

81. Cecil KM, Patel NC, DelBello MP. Inositol metabolism in pediatric bipolar disorder. Clinical Neuropsychiatry 3:177-183, 2006.

82. Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM: The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J Child Adolesc Psychopharmacol, 16:665-670, 2006.

83. Strakowski SM, Adler CM, DelBello MP: Metabolic dysfunction within the anterior limbic network in bipolar disorder: a model for studying new treatments. Neuropsychiatria i Neuropsychologia 1:5-14, 2006.

84. DelBello MP, Cecil KM, Adler CM, Daniels JP, Strakowski SM: Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology 31: 1264-1273, 2006.

2007

85. Strakowski SM, DelBello MP, Fleck DE, Adler CM, Anthenelli RM, Keck PE Jr, Arnold LM, Amicone J: Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry 64:57-64, 2007.

86. Singh MK, DelBello MP, Adler CM. Acute dystonia associated with aripiprazole in a child. J Am Acad Child Adolesc Psychiatry 46:306-307, 2007.

87. Barzman DH, DelBello MP, Fleck DE, Lehmkuhl H, Strakowski SM: Rates, types, and psychosocial correlates of legal charges in adolescents with newly diagnosed bipolar disorder. Bipolar Disord 9:339-344, 2007

88. Patel NC, Patrick DM, Youngstrom EA, Strakowski SM, DelBello MP: Response and remission in adolescent mania: signal detection analyses of the Young Mania Rating Scale. J Am Acad Child Adolesc Psychiatry 46: 628-635, 2007.

89. DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM: Twelve month outcome of adolescents with bipolar disorder following first-hospitalization for a manic or mixed episode. Am J Psychiatry. 164:582-590, 2007.

90. Singh M, DelBello MP, Stanford KE, Soutullo CA, McDonough-Ryan P, McElroy SL, Strakowski SM: Psychopathology in children of bipolar parents. J Affect Disord 1-6, 2007.

91. Patel NC, Hariprasad M, Matias-Akthar M, Sorter MT, Barzman DH, Morrison JA, Stanford KE, Strakowski SM, DelBello MP. Body mass indices and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychotics. J Child Adolesc Psychopharmacol 17:303-311, 2007.

92. Rademacher J, DelBello MP, Adler CM, Stanford K, Strakowski SM: Health-related quality of life in adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 17:97-103, 2007.

93. Adams J, Adler CM, Jarvis K, DelBello MP, Strakowski SM, Evidence of Anterior Temporal Atrophy in College-Level Soccer Players Clin J Sport Med 17:304-306, 2007.

94. DelBello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM: A 12-week single-blind trial of quetipine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.  J Clin Psychiatry 68:789-795, 2007.

95. Adler CM, DelBello MP, Jarvis K, Levine A, Adams J, Strakowski SM: Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry 61:776-781, 2007.

96. Giles LL, DelBello MP, Stanford KE, Strakowski SM: Child Behavior Checklist profiles of children and adolescents with and at high risk for developing bipolar disorder. Child Psychiatry Hum Dev. 38:47-55, 2007.

97. Barzman DH, DelBello MP, Forrester JJ, Keck PE, Strakowski SM: A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: a retrospective chart review: is sedation desirable? J Child Adolesc Psychopharmacol 17:503-509, 2007.

98. Strakowski SM, Tsai S-Y, DelBello MP, Fleck DE, Adler CM, Arndt S, Amicone J. Outcome following a first manic episode: Cross-national U.S. and Taiwan comparison. Bipolar Disord 9: 820-827, 2007.

99.Difrancesco MW, Holland SK, Ris MD, Adler CM, Nelson S, DelBello MP, Altaye M, Brunner HI. Functional magnetic resonance imaging of cognitive function in childhood-onset systemic lupus erythematosus: a pilot study. Arthritis & Rheumatism 56:4151-4163, 2007.

 100.Tohen M, Kryzhanovskaya L, Carlson G, DelBello MP, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Huang X, Dittman R, Biederman J: Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 164:1547-1556, 2007.

 101. Pfeifer JC, Kowatch RA, DelBello MP:  The use of antipsychotics in children and adolescents

         with bipolar disorders.  Expert Opin Pharmacother 8:2673-2687, 2007.

 102.  DelBello MP, Correll CU, Carlson GA, Carlson HE:  Pharmacological management of bipolar

         disorder in a youth with diabetes.  J Am Acad Child Adolesc Psychiatry 46:1375-1379, 2007.  

 103.Singh MK, Pfeifer JC, Barzman DH, Kowatch RA, DelBello MP: Medical management of 

         pediatric mood disorders. Pediatr Ann 36:552-563, 2007.

                              2008

104.                        Strawn JR, DelBello MP:  Olanzapine for the treatment of bipolar disorder in children and adolescents. Expert Opin Pharmacother 9:467-474, 2008.

105.                        Patel NC, DelBello MP, Cecil Km, Stanford KE, Adler CM, Strakowski SM: Temporal change in N-acetyl-asparate concentrations in adolescents with bipolar depression treated with lithium.  J Child Adolesc Psychopharmacol 18:132-139, 2008.

106.  Singh MK, DelBello MP, Adler CM, Stanford KE, Strakowski SM: Neuroanatomical  

characterization of child offspring of bipolar parents. J Am Acad Child Adolesc Psychiatry 47:526-531, 2008.

  1. Strawn JR, Adler CM, Strakowski SM, DelBello MP: Hyperthermia and rhabdomyolysis in an   adolescent treated with topiramate and olanzapine. J Child Adolesc Psychopharmacol 18:116 118, 2008.
  2. Giles L, DelBello MP, Stanford K, Strakowski SM: Cerebellar ataxia in youth at risk for bipolar disorder. Bipolar Disord 10:733-737, 2008.
  3. Pfeifer JC, Welge J, Strakowski SM, Adler CM, DelBello MP: Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 47:1289-1298, 2008.
  4. Fleck DE, Nandagopal J, Cerullo MA, Eliassen JC, DelBello MP, Adler CM, Strakowski SM:  Morphometric magnetic resonance imaging in psychiatry.  Top Magn Reson Imaging. 19:131-142, 2008.
  5. Cerullo MA, Albertz AA, Bell JN, Anthenelli, RM, DelBello MP: Tricyclic antidepressant

         immunoassays may reflect quetiapine adherence. Am J Psychiatry 165:919-920, 2008.

112.  Strakowski SM, Adler CM, Cerullo MA, Eliassen JC, Lamy M, Fleck DE, Lee J, DelBello MP:      MRI brain activation in first-episode bipolar mania during a response inhibition task. Early Interv Psychiatry 2:225-233, 2008

113.  DelBello MP, Versavel M, Ice K, Keller D, Miceli J, Tolerability of Oral Ziprasidone in Children and Adolescents with Bipolar Mania, Schizophrenia, or Schizoaffective Disorder. J Child Adolesc Psychopharmacol 18:491-499, 2008.

114.  Heffner JL, DelBello MP, Fleck DE, Anthenelli RM, Strakowski SM:  Cigarette smoking in the early course of bipolar disorder: association with ages-at-onset of alcohol and marijuana use. Bipolar Disord 10:838-845, 2008.

115.  Patel NC, Cecil KM, Strakowski SM, Adler CM, DelBello MP: Neurochemical alterations in adolescent bipolar depression: A proton magnetic resonance spectroscopy pilot study of the prefrontal cortex. J Child Adolesc Psychopharmacol 18: 623-627, 2008

116.   Singh MK, DelBello MP, Strakowski SM: Temperament in child offspring of parents with bipolar disorder. J Child Adolesc Psychopharmacol 18:589-593, 2008.

117.  Jarvis K, DelBello MP, Mills N. Elman I, Strakowski SM, Adler, CM:  Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders.  J Child Adolesc Psychopharmacol 18:557-563, 2008.

                                                                    

                                                                     2009

118.  Geller B, Harms MP, Wang L, Tillman R, DelBello MP, Bolhofner K, Csernansky J: Effects of age, sex and independent life events on amygdala and nucleus accumbens volumes in child bipolar I disorder. Biol Psychiatry 65:432-437, 2009.

119.   Carlson GA, Findling RL, Post RM, Birmaher B, Blumberg HP, Correll C, DelBello MP, Fristad M, Frazier J, Hammen C, Hinshaw SP, Kowatch R, Leibenluft E, Meyer SE, Pavuluri MN, Wagner KD, Tohen M:  AACAP 2006 research forum-advancing research in early-onset bipolar disorder: barriers and suggestions.  J Child Adolesc Psychopharmacol 19:3-12, 2009.

120.  Strakowski SM, DelBello MP, Adler CM, Shear PK, Fleck DE, McElroy SL, Keck PE, Moss Q,      Cerullo MA, Kotwal R, Kaneria R, Arndt S: Characterizing impulsivity in mania. Bipolar Disord 11:41-51, 2009.

121.  Nandagopal JN, DelBello, MP, Kowatch R.  Pharmacologic treatment of pediatric bipolar disorder. Child Adolesc Psychiatric Clin North America 18:455-469, 2009.

122.  Epstein JN, DelBello MP, Adler, CM, Mekibib A, Kramer M, Mills MP, Strakowski SM, Holland S.  Differential patterns of brain activation over time in adolescents with and without attention deficit hyperactivity disorder (ADHD) during performance of a sustained attention task Neuropediatrics  40:1-5, 2009.

123.  DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.  A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord 11:483-493, 2009.

124.  Perlis RH, Dennehy EB, Miklowitz DJ, DelBello MP, Ostacher M, Calabrese JR, Ametrano RM, Wisniewski SR, Bowden CL, Thase ME, Nierenberg AA, Sachs G. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.  Bipolar Disord 11:391-400, 2009.

125.  Singh MK, DelBello MP, Fleck DE, Shear PK, Strakowski SM.  Inhibition and attention in adolescents with nonmanic mood disorders and a high risk for developing mania. J Clin Exp Neuropsychol 31:1-7, 2009. 

126.  Stewart M, DelBello MP, Versavel M, Keller D. Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.  J Child Adolesc Psychopharmacol 19: 635-640, 2009.

127.  Strawn JR, DelBello MP, Geracioti TD.  Prazosin treatment of an adolescent with posttraumatic stress disorder.  J Child Adolesc Psychopharmacol 19:599-600, 2009. 

128. Haas M, DelBello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.  Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.  Bipolar Disord 11:687-700, 2009. 

129.  Cerullo MA, Adler CM, Lamy M, Eliassen JC, Fleck DE, Strakowski SM, DelBello MP.

Differential brain activation during response inhibition in bipolar and attention-deficit

hyperactivity disorders. Early Intervention in Psychiatry 3:189-197, 2009.

130.  Nandagopal, JJ, DelBello MP.  Selegiline transdermal system: A novel treatment option for major depressive disorder.  Expert Opin Pharmacoth. 10:1665-1673, 2009.

131.  Cerullo MA, Adler CM, DelBello MP, Strakowski SM.  The functional neuroanatomy of bipolar disorder.  International Review Psychiatry 21:314-322, 2009.

                                                                          2010

132. McNamara RK, Able J, Jandacek R, Rider T, Tso P, Eliassen JC, Alfieri D, Weber W, Jarvis K, DelBello MP, Strakowski SM, Adler CM. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: A placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr 9:1060-1067, 2010.

133. DelBello MP, Correll CU.  Primum non nocere: Balancing the risks and benefits of prescribing psychotropic medications for youth with bipolar disorder.  Bipolar Disord 12:113-115, 2010.

134. Correll CU, Sheridan EM, DelBello MP:  Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: A comparative analysis of acute, randomized, placebo-controlled trials.  Bipolar Disord 12:116-141, 2010. 

135. Strawn JR, Keeshin BR, DelBello MP, Geracioti TD Jr., Putnam FW.  Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: A review.  J Clin Psychiatry 71:932-941, 2010

136. Pfeifer JC, Kowatch RA, DelBello MP. Pharmacotherapy of bipolar disorder in children and adolescents: recent progress.  CNS Drugs 24:575-593, 2010.

137. Strawn JR, Adler CM, Fleck DE, Hanseman D, Maue DK, Bitter S, Kraft EM, Geracioti TD, Strakowski SM, DelBello MP. Post-traumatic stress symptoms and trauma exposure in youth with first episode bipolar disorder. Early Interv Psychiatry 4:169-173, 2010.

138.  Strakowski SM, Fleck DE, DelBello MP, Adler CM, Shear PK, Kotwal R, Arndt S. Impulsivity across the course of bipolar disorder. Bipolar Disord., 12:285-297, 2010.

139.  McNamara RK, Nandagopal JJ, Strakowski SM, DelBello MP:  Preventative strategies for early-onset bipolar disorder: towards a clinical staging model.  CNS Drugs, 24: 983-996, 2010.

                                                                      2011

140. Strawn J, Whitsel R, Nandagopal JJ, DelBello MP.  Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine.  J child Adolesc Psychopharmacol 21:91-92, 2011. 

141. Shahana N, DelBello MP, Chu W-J, Jarvis KB, Fleck, D, Welge J, Strakowski SM, Adler CM.  Neurochemical alteration in the caudate:  Implications for the pathophysiology of bipolar disorder.  Psychiatry Research: Neuroimaging. 193:107-112, 2011.

142.  Lisy ME, Jarvis KB, DelBello MP, Mills NP, Webber WA, Fleck D, Strakowski SM, Adler CM.  Progressive neurostructural changes in adolescent and adult patients with bipolar disorder.  Bipolar Disorder 13:396-405, 2011.

143.  Fleck DE, Kotwal R, Eliassen JC, Lamy M, DelBello MP, Adler CM, Durling M, Cerullo MA, Strakowski SM.   Preliminary evidence for increased frontosubcortical activation on a motor impulsivity task in mixed episode bipolar disorder.  J Affect Disord.  133:333-339, 2011.

144.  Axelson DA, Birmaher B, Findling RL, Fristad MA, Kowatch RA, Youngstrom EA, Arnold EL, Goldstein BI, Goldstein TR, Chang KD, DelBello MP, Ryan ND, Diler RS. Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J Clin Psychiatry. 79:1257-1262, 2011.

145.  Bitter SM, Mills NP, Adler CM, Strakowski SM, DelBello MP.  Progression of amygdala volumetric abnormalities in adolescents after their first manic episode. J Am Acad Child Adolesc Psychiatry, 50:1017-1026, 2011

146. Nandagopal JJ, Fleck DE, Adler CM, Mills NP, Strakowski SM, DelBello MP. Impulsivity in Adolescents with Bipolar Disorder and ADHD as Measured by the Barratt's Impulsiveness Scale (BIS-11), J Child Adolesc Psychopharm, 21:465-468, 2011.

147.  Strakowski SM, Eliassen JC, Lamy M, Cerullo MA, Allendorfer JB, Madore M, Lee JH, Welge JA, DelBello MP, Fleck DE, Adler CM:  Functional magnetic resonance imaging brain activation in bipolar mania:  Evidence for disruption of the ventrolateral prefrontal-amygdala emotional pathway.  Biol Psychiatry, 15:381-388, 2011.

148.  Heffner JL, Strawn JR, DelBello MP, Strakowski SM, Anthenelli RM.  The co-occurrence of cigarette smoking and bipolar disorder:  Phenomenology and treatment consideration.  Bipolar Disorder, 13: 439-453, 2011.

                                                                          2012

149.  Cerullo MA, Fleck DE, Eliassen JC, Smith MS, DelBello MP, Adler CM, Strakowski SM.  A longitudinal functional connectivity analysis of the amygdala in bipolar I disorder across mood states.  Bipolar Disorder, 14:175-184, 2012. 

150. Heffner JL, DelBello MP, Anthenelli RM, Fleck DE, Adler CM, Strakowski SM. Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder. Bipolar Disorder. 14:99-108, 2012.  

151.  Fleck DE, Eliassen JC, Durling M, Lamy M, Adler CM, DelBello MP, Shear PK, Cerullo MA, Lee JH, Strakowski SM.  Functional MRI of sustained attention in bipolar mania.  Mol Psychiatry, 17:325-336, 2012

152.  Strawn JR, Patel NC, Chu W-J, Lee JH, Adler CM, Kim MJ, Bryan HS, Alfieri DC, Welge JA, Blom TJ, Nandagopal JJ, Strakowski SM, DelBello MP.  Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study.  J Am Acad Child Adolesc Psychiatry, 51:642-651, 2012.

153.  Schneider MR, DelBello MP, McNamara RK, Strakowski SM, Adler CM.  Neuroprogression in bipolar disorder.  Bipolar Disorder, 14:356-374, 2012. 

154.  Strakowski SM, Adler CM, Almeida J, Altshuler LL, Blumberg HP, Chang KD, DelBello MP, Frangou S, McIntosh A, Phillips ML, Sussman JE, Townsend JD.  The functional neuroanatomy of bipolar disorder: A consensus model.  Bipolar Disorder, 14:313-325, 2012.

155.  Strawn JR, Wehry AM, DelBello MP, Rynn MA, Strakowski SM.  Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder.  Depress Anxiety, 29:328-339, 2012.

156.  Black JJ, Heffner JL, Anthenelli RM, Beavers JN, Albertz A, Blom T, Adler CM, DelBello MP.  Diagnosing alcohol and cannabis use disorders in adolescents with bipolar disorder: A preliminary investigation.  J Dual Diagnosis, 8:13-18, 2012.

157.  Olsen BT, Ganocy SJ, Bitter SM, Findling RL, Case M, Chang K, Tohen M, DelBello MP.   Health-related quality of life as measured by the child health questionnaire in adolescents with bipolar disorder treated with olanzapine.   Compre Psychiatry. 53:1000-1005, 2012

158.  Strawn JR, Bitter SM, Weber WA, Chu W-J, Whitsel RM, Adler CM, Cerullo MA, Eliassen J, Strakowski SM, DelBello MP.  Neurocircuitry of generalized anxiety disorder in adolescents: A pilot functional neuroimaging and functional connectivity study.  Depress Anxiety, 29:939-947, 2012.

159. McNamara RK, Strawn JR, Chang KD, DelBello MP. Interventions for youth at high risk for bipolar disorder and schizophrenia. Child Adolesc Psychiatr Clin N Am. 21:739-751, 2012.

160.  Heffner JL, Fleck DE, DelBello MP, Adler CM, Strakowski SM. Cigarette smoking and impulsivity in bipolar disorder.  Bipolar Disord. 14:735-742, 2012.

161.  Schneider MR, Adler CM, Whitsel R, Weber W, Mills NP, Bitter SM, Eliassen J, Strakowski SM, DelBello MP. The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder.  Isr J Psychiatry Relat Sci. 49:112-120, 2012.

162.  Heffner JL, DelBello MP, Fleck DE, Adler CM, Strakowski SM.  Unplanned pregnancies in adolescents with bipolar disorder.  Am J Psychiatry, 169:1319, 2012.

                                                                          2013

163.  Southammakosane C, Danielyan A, Welge JA, Blom TJ, Adler CM, Chang KD, Howe M, DelBello MP. Characteristics of the child behavior checklist in adolescents with depression associated with bipolar disorder.  J Affect Disord. 145:405-408, 2013.

164.  Adler CM, DelBello MP, Weber WA, Jarvis KB, Welge J, Chu W-J, Rummelhoff E, Kim MJ, Lee JH, Strakowski SM.  Neurochemical effects of quetiapine in patients with bipolar mania: A proton magnetic resonance spectroscopy study.  J Clin Psychopharmacol., 33: 528-532, 2013. 

165.  Strawn JR, Chu W-J, Whitsel RM, Weber WA, Norris MM, Adler CM, Eliassen JC, Phan KL, Strakowski SM, DelBello MP.  A pilot study of anterior cingulated cortex neurochemistry in adolescents with generalized anxiety disorder.  Neuropsychobiology, 67:224-229, 2013. 

166.  McNamara RK, Jandacek R, Tso P, Weber WA, Chu W-J, Strakowski SM, Adler CM, DelBello MP.  Low docosahexaenoic acid status is associated with reduced indices in cortical integrity in the anterior cingulated of healthy male children.  Nutr Neurosci., 16:183-190, 2013.

167.  Patino LR, Adler CM, Mills NP, Strakowski SM, Fleck DE, Welge JA, DelBello MP.  Conflict monitoring and adaptation in individuals at familial risk for developing bipolar disorder.  Bipolar Disord., 15:264-271, 2013. 

168.  Findling RL, Pathak S, Earley WR, Acevedo LD, Stankowski J, DelBello MP.  Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: A 3-233k, double-bling, placebo-controlled trial.  J Clin Psychiatry, 74: e100-e109, 2013.

169.  Keeshin BR, Luebbe AM, Strawn JR, Saldana SN, Wehry AM, DelBello MP.  Sexual abuse is associated with obese children and adolescents admitted for psychiatric hospitalization.  J Pediatr., 163:154-159, 2013. 

170.  Welge JA, DelBello MP.  Treatment of youth with bipolar disorder: Long-term versus maintenance.  Bipolar Disord., 15:150-152, 2013.

171.  Chu W-J, DelBello MP, Jarvis KB, Norris MM, Kim MJ, Weber WA, Lee JH, Strakowski SM, Adler CM.    Magnetic resonance spectroscopy imaging of lactate in patients with bipolar disorder.  Psychiatry Res., 30:230-234, 2013.

172.  Heffner JL, Anthenelli RM, DelBello MP, Stahl L, Strakowski SM.  Mood management and nicotine patch for smoking cessation in adults with bipolar disorder.  Nicotine Tob Res., 15:1805-1806, 2013.

173.  Weber WA, Dudley J, Lee JH, Strakowski SM, Adler CM, DelBello MP.  A pilot study of alterations in high energy phosphoryl compounds and intracellular pH in unmedicated adolescents with bipolar disorder.  J Affect Disord., 25:1109-1113, 2013.

174.  Heffner JL, Anthenelli RM, Adler CM, Strakowski SM, Beaver J, DelBello MP.   Prevalence and correlates of heavy smoking and nicotine dependence in adolescents with bipolar and cannabis use disorders.   Psychiatry Res., 210:857-862, 2013.

175.  Barzman DH, Mossman D, Appel K, Blom TJ, Strawn JR, Ekhator NN, Patel B, DelBello MP, Sorter M, Klein D, Geracioti TD Jr.  The association between salivary hormone levels and children’s in patient aggression.  A pilot study.  Psychiatr Q.  84:475-484, 2013.

176.  Strawn JR, Wehry AM, Chu W-J, Adler CM, Eliassen JC, Cerullo MA, Strakowski SM, DelBello MP.   Neuroanatomic abnormalities in adolescents with generalized anxiety disorder: A voxel-based morphometry study.  Depress Anxiety.  30:842-848, 2013.

177.  Findling RL, Cavus I, Pappadopulos E, Vanderburg DG, Schwartz JH, Gundapaneni BK, DelBello MP.  Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study.  J Child Adolesc Psychopharmacol., 23:531-544, 2013.

 178. Kemp DE, Correll CU, Tohen M, DelBello MP, Ganocy SJ, Findling RL, Chang K.  Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.  J Child Adolesc Psychopharmacol., 23:522-530, 2013. 

179.  Findling RL, Cavus I, Pappadopulos E, Vanderburg DG, Schwartz JH, Gundapaneni BK, DelBello MP.  Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.  J. Child Adolesc Psychopharmacol., 23:545-557, 2013.

180.  Strakowski SM, Adler CM, DelBello MP.   Is depression simply a nonspecific response to brain injury?  Curr Psychiatry Rep., 15:386, 2013.

                                                                          2014

181.  Donfrancesco R, Marano A, Innocenzi M, Toni L, Di Lelio A, Milone A, Sposato M, Mazzotta G, Valenti V, Melegari MG, DelBello MP.  A comparison of bipolar disorders in children in Italy and United States.  J Affect Disord., 159:53-55, 2014.  

182.  Bitter SM, Weber WA, Chu W-J, Adler CM, Eliassen JC, Strakowski SM, DelBello MP.  N-acetyl aspartate levels in adolescents with bipolar and/or cannabis use disorders.  J Dual Diagn., 10:39-43, 2014.

183.  Keeshin BR, Strawn JR, Luebbe AM, Saldana SN, Wehry AM, DelBello MP, Putnam FW.  Hospitalized youth and child abuse: a systematic examination of psychiatric morbidity and clinical severity.  Child Abuse Negl., 38:76-83, 2014. 

184.  Strawn JR, Adler CM, McNamara RK, Welge JA, Bitter SM, Mills NP, Barzman DH, Cerullo MA, Chang KD, Strakowski SM, DelBello MP.  Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a perspective naturalistic treatment study.  Bipolar Disord., 16:523-530, 2014. 

185.  Miklowitz DJ, Schneck CD, George EL, Taylor DO, Sugar CA, Birmaher B, Kowatch RA, DelBello MP, Axelson DA.   Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: A 2-year randomized trial.  Am J Psychiatry, 171: 658-667, 2014.

186.  Correll CU, Hauser M, Penzner JB, Auther AM, Kafantaris V, Saito E, Olvet D, Carrion RE, Birmaher B, Chang KD, DelBello MP, Singh MK, Pavuluri M, Cornblatt BA.  Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode.   Bipolar Disord., 16:478-492, 2014.

187.  Schneider MR, Klein CK, Weber WA, Bitter SM, Elliott KB, Strakowski SM, Adler CM, DelBello MP.  The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder.  Psychiatry Research.  223: 268-270, 2014.

188.  McNamara RK, Strimpfel J, Jandacek R, Rider T, Tso P, Welge JA, Strawn JR, DelBello MP.  Detection and treatment of long-chain omega-3 fatty acid deficiency in adolescents with SSRI-resistant major depressive disorder.  Pharma Nutrition. 2:38-46, 2014.  

189.  Stephens JR, Heffner JL, Adler CM, Blom TJ, Anthenelli RM, Fleck DE, Welge JA, Strakowski SM, DelBello MP.   Risk and protective factors associated with substance use disorders in adolescents with first-episode mania.  J Am Acad Child Adolesc Psychiatry.  53: 771-779, 2014. 

190.  DelBello MP, Hochadel TJ, Portland KB, Azzaro AJ, Katic A, Khan A, Emslie G.  A double-blind placebo-controlled study of selegiline transdermal system in depressed adolescents.  J Child Adolesc Psychopharmacol., 24:311-317, 2014. 

191.  Bitter SM, Adler CM, Eliassen JC, Weber WA, Welge JA, Burciaga J, Shear PK, Strakowski SM, DelBello MP.   Neurofunctional changes in adolescents cannabis users with and without bipolar disorder.  Addiction.  109: 1901-1909, 2014.

192.  Saldana SN, Keeshin BR, Wehry AM, Blom TJ, Sorter MT, DelBello MP, Strawn JR.   Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.  Pharmacotherapy, 34: 836-844, 2014.

193.  Strawn JR, Wegman JC, Dominick KC, Swartz MS, Wehry AM, Patino LR, Strakowski SM, Adler CM, Eliassen JC, DelBello MP.  Cortical surface anatomy in pediatric patients with generalized anxiety disorder.   J Anxiety Disord., 28: 717-723, 2014.

194.  Cerullo MA, Eliassen JC, Smith CT, Fleck DE, Nelson EB, Strawn JR, Lamy M, DelBello MP, Adler CM, Strakowski SM.  Bipolar I disorder and major depressive disorder show similar brain activation during depression.  Bipolar Disord., 16:703-712, 2014.

195.  Dawson EL, Shear PK, Howe SR, Adler CM, DelBello MP, Fleck DE, Strakowski SM.  Impulsivity predicts time to reach euthymia in adults with bipolar disorder.  Bipolar Disord., 16:846-856, 2014.

196.  Miklowitz DJSchneck CD, Birmaher B, DelBello MP, Axelson DA.   Response to parikh.  Am J Psychiatry.  171:1335-1336, 2014.

197.  Donfrancesco R, Di Trani M, Andriola E, Leone D, Torrioli MG, Passarelli F, DelBello MP.  Bipolar disorder in children with ADHD: A clinical sample study.   J Atten Disord., 2014 [Epub ahead of print]

198.  Davis AK, DelBello MP, Eliassen J, Welge J, Blom TJ, Fleck DE, Weber WA, Jarvis KB, Rummelhoff E, Strakowski SM, Adler CM.  Neurofunctional effects of quetiapine in patients with bipolar mania.  Bipolar Disord., 2014. [Epub ahead of print].

                                                                          2015

199.  Wehry AM, McNamara RK, Adler CM, Eliassen JC, Croarkin P, Cerullo MA, DelBello MP, Strawn JR.  Neurostructural impact of co-occurring anxiety in pediatric patients with major depressive disorder: A voxel-based morphometry study.  J Affect Disord., 171:54-59, 2015.

200.  Detke HC, DelBello MP, Landry J, Usher RW.  Olanzapine/fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-bline, placebo-controlled trial.   J Am Acad Child Adolesc Psychiatry.  54:217-224, 2015.

201.   Cotton S, Luberto CM, Sears RW, Strawn JR, Stahl L, Wasson RS, Blom TJ, DelBello MP.  Mindfulness-based cognitive therapy for youth with anxiety disorders at risk for bipolar disorder: A pilot trial.  Early Interv Psychiatry, 2015 [Epub ahead of print]

202.  McNamara RK, Jandacek R, Rider T, Tso P, Chu WJ, Weber WA, Welge JA, Strawn JR, Adler CM, DelBello MP.  Effect of fish oil supplementation on prefrontal metabolite concentration in adolescents with major depressive disorder: A preliminary 1H MRS study.  Nutr Neurosci., 2014 [Epub ahead of print]

Solicited Reviews & Book Chapters:

1.   Strakowski SM, DelBello MP: The co-occurrence of bipolar and substance use disorders. Clin Psychol Rev 20:191-206, 2000.

2 Strakowski SM, DelBello MP, Adler CA: Comparative tolerability of drug treatments for bipolar disorder. CNS Drugs 15:701-718, 2001.

3.   Nelson EB, Soutullo CA, DelBello MP, McElroy SL:  The psychopharmacological treatment of sex offenders. The Sex Offender, Vol. 4, Barbara K. Schwartz (ed.), Civic Research Institute, 2002.

  1. DelBello MP, Kowatch RA: Lithium. In: Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders. Rosenberg D, Davanzo P, Gershon S (eds.), Brunner Mazel, Inc., 2002.
  2. DelBello MP, Strakowski SM: The Impact of substance abuse on the course of bipolar disorder. Directions in Psychiatry 2002.
  3. Keck PE, DelBello MP:  Advances in pharmacologic treatment: bipolar mania. Current Psychiatry 1:6–12, 2002.

7.   DelBello MP, Kowatch RA, Keck PE, Jr.: New antiepileptic agents for the treatment of bipolar disorder. Child and Adolescent Psychopharmacology Newsletter, 7:1-4, 2002.

8.   DelBello MP, Strakowski SM: The co-occurrence of affective and substance use disorders.   In: Integrating Treatment for Mood and Substance Disorders J Westermeyer, RD Weiss, (eds.), Johns Hopkins Press, 2003.

9.   DelBello MP, Kowatch RA: Neuroimaging in pediatric bipolar disorder. In: Bipolar Disorder in Childhood and Early Adolescence. Geller B, DelBello MP (eds.), Guilford Publication, Inc.,

2003.

10. DelBello MP, Axelson D, Geller B: Introduction to bipolar disorder in childhood and early adolescence.  In: Bipolar Disorder in Childhood and Early Adolescence. Geller B, DelBello MP (eds.), Guilford Publication, Inc., 2003.

11. Geller B, Craney JL, Bolhofner K, DelBello MP, Axelson D, Luby J, Williams M, Zimerman B, Nickelsburg MJ, Frazier J, Beringer L: Phenomenology and Longitudinal Course of Children with a Prepubertal and Early Adolescent Bipolar Disorder Phenotype.  In: Bipolar Disorder in Childhood and Early Adolescence. Geller B, DelBello MP (eds.), Guilford Publication, Inc., 2003.

12. Kowatch, RA, DelBello MP:  The use of mood stabilizers and atypical antipsychotics in children and adolescents with bipolar disorders. CNS Spectrums 8:273-280, 2003.

13. Kowatch, RA, DelBello MP: How to recognize and treat children and adolescents with bipolar disorders. Current Psychiatry 2:41-47, 2003.

14. DelBello MP, Kowatch RA:  Mood disorders in childhood and adolescent-basic mechanisms and therapeutic interventions. In: The Handbook of Medical Psychiatry. Soares JC, Gershon S (eds.), Marcel Dekker, Inc., 2003.

15. DelBello MP, Grcevich S:  Phenomenology and epidemiology of childhood psychiatric disorders that may necessitate treatment with atypical antipsychotics. J Clin Psychiatry 65 Suppl 6:12-19, 2004.

16. DelBello MP, Strakowski SM: Neurochemical predictors of response to pharmacological                                           treatments for bipolar disorder. Curr Psychiatry Rep 6:466-472, 2004.

17. Barzman DH, DelBello MP. Clinically useful approaches for the atypical antipsychotics (second generation antipsychotics) in pediatric psychotic disorders.  Child Adolesc Psychopharmacology News 9: 6-9, 2004.

18. Kowatch RA, DelBello MP: Pharmacotherapy of children and adolescents with bipolar disorder. Psychiatr Clin North Am 28:385-397, 2005.

19. Pfeifer JC, DelBello MP, Holland SK: Anatomical and functional neuroimaging studies of children and adolescents with attention deficit hyperactivity disorder (ADHD). In: Attention Deficit Hyperactivity Disorder: From Genes to Animal Models to Patients.  Gozal D, Molfese D (eds.), Humana Press, 2005.

20. Kowatch RA, DelBello MP, Mayes T, Kennard, BD, Emslie GJ: Pediatric mood disorders. In: Textbook of Essential Neuropsychiatry. Cofey E, Brumback RA, Rosenberg DR, Voeller K (eds.), Lippincott Williams and Wilkins, 263-284, 2006.

21. Kowatch RA, DelBello MP: Pediatric bipolar disorder: emerging diagnostic and treatment approaches. Child Adolesc Psychiatr Clin N Am 15:73-108, 2006.

22. Patel NC, DelBello MP: Antipsychotic medications in pediatric patients: The importance of safety and tolerability. Directions in Psychiatry, 26:251-263, 2006.

23. Singh M, Pfeifer J, Barzman D, Kowatch R, DelBello MP: Pharmacotherapy for child and adolescent mood disorders. Psychiatric Annals 37: 465-476, 2007.

24. DelBello MP, Adler CM, Cerullo M, Fleck D, Strakowski SM: Bipolar disorder. In: New Encyclopedia of Neuroscience, 2007. 

25. Singh MK, Pfeifer JC, Barzman DH, Kowatch RA, DelBello MP: Medical management of

      pediatric mood disorders. Pediatr Ann 36:552-563, 2007.

26. Patel NC, DelBello MP: Neuropharmacology In: Treatment of Childhood and Adolescent Bipolar Disorder. Geller B and DelBello MP (eds.), Guilford Press, New York, NY, 2008.

27. DelBello MP, Geller B: Introduction. In: Treatment of Childhood and Adolescent Bipolar Disorder, Guilford Press, New York, NY, 2008.

28. Fleck DE, Nandagopal J, Cerullo MA, Eliassen JC, DelBello MP, Adler CM, Strakowski SM. Morphometric magnetic resonance imaging in psychiatry. Top Magn Reson Imaging 19:131-142, 2008.

29. Cerullo MA, Adler CM, DelBello MP, Strakowski SM. The functional neuroanatomy of

bipolar disorder.  International Review of Psychiatry, 21: 314-322, 2009.

30. Patel NC, Cerullo MA, Fleck DE, Nandagopal JJ, Adler CM, Strakowski SM, DelBello MP.    Neuroimaging biomarkers for bipolar disorder across the lifespan. In: Ritsner MS, ed. Neuropsychiatric Biomarkers, Endophenotypes, and Genes: New York, NY: Springer Publishing Company, Volume 1: XIV, pp. 274, 2009.

31. Fleck DE, Cerullo MA, Nandagopal J, Adler CM, Patel NC, Strakowski SM, DelBello MP. Neurodevelopment in bipolar disorder: A neuroimaging perspective. In: Miklowitz and Cicchetti, Understanding bipolar disorder a developmental psychopathology perspective. Guilford Press, New York, NY, 2010.

32. Kowatch RA, Strawn JR, DelBello MP. Developmental considerations in the pharmacological treatment of youths with bipolar disorder. In: Miklowitz and Cicchetti, eds. Understanding bipolar disorder a developmental psychopathology perspective. Guilford Press, New York, NY, 2010.

Books:

1.   Geller B, DelBello MP (eds.): Bipolar Disorder in Childhood and Early Adolescence. Guilford Press, New York, NY, 2003

2.  Geller B, DelBello MP (eds.): Treatment of Childhood and Adolescent Bipolar Disorder. Guilford Press, New York, NY, 2008.

Other Publications:

1.   DelBello, MP: Attending the APA annual meeting and meeting “famous” psychiatrists: A resident’s perspective. APA Research Report, Residents’ and Fellows’ Corner, Summer 1999.

2.   DelBello MP: Surviving a job search. APA Research Report, Residents’ and Fellows’ Corner, Spring 2000.

3.   DelBello MP: There’s no place like home, There’s no place like home. APA Research Report, Residents’ and Fellows’ Corner, Spring/Summer, 2001.

4.   DelBello MP: Women as psychiatric researchers: A decade later. APA Research Report, Residents’ and Fellows’ Corner, Fall/Winter, 2001.

5.   DelBello MP: Psychiatric Travel Awards 101. APA Research Report, Residents’ and Fellows’ Corner, Spring, 2002.

6.   DelBello MP: Writing an NIMH Career Development award (a.k.a. “K award”): Part I. APA Research Report, Residents’ and Fellows’ Corner, Summer, 2002.

7.   DelBello MP: Effects of Ethnicity on Psychiatric Diagnosis: A Developmental Perspective.  Psychiatric TimesMarch, 2002.

8.   DelBello MP:  Reducing the impact of bipolar disorder: a developmental perspective.  Commentary on the economic and social burden of bipolar disorder, Goldberg J and Ernst C, In: Bipolar Disorder Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N (eds.), WPA series, Evidence and Experience in Psychiatry, vol 5, John Wiley and Sons LTD, 2002.

9.   DelBello MP:  Writing an NIMH Mentored Career Development Award (a.k.a. “K award”): Part II. APA Research Report, Building Research Careers, Fall/Winter, 2002

10. DelBello MP: Writing an NIMH Mentored Career Development Award (a.k.a. “K award”): Part III, APA Research Report, Building Research Careers, Spring, 2003.

11. DelBello MP: Industry vs. inferiority.  APA Research Report, Building Research Careers, Summer, 2003.

12. DelBello MP: Beginning to mentor. APA Research Report, Building Research Careers, Spring, 2004.

13. DelBello MP: The phenomenology and pharmacology of bipolar disorders in children and adolescents.  MEASURE minutes, first quarter, 2004. 

14. Post, RM, Janicak PG, DelBello MP: Treatment of bipolar mania (Section Ed. Ginsberg DL), CNS Spectr. 9(1 suppl 1); S1-S2, 2004

15. DelBello MP: The “K Years”: Don’t miss out on the fun. APA Research Report, Winter, 2005.

16. DelBello MP: The treatment of bipolar depression in children and adolescents. MEASURE minutes, 2005.

17. DelBello MP, Chang KD: Bipolar disorder in children and adolescents – are we approaching the final frontier? Bipolar Disor, 7:479-482, 2005.

18. DelBello MP: The past, future, and present of childhood and adolescent mental health. J Clin Psychiatry. 67:114, 2006.

19. DelBello MP: Focus on Childhood and Adolescent Mental Health. J Clin Psychiatry. 67:5-6, 2006.

20. DelBello MP: Phenomenological considerations of childhood and adolescent psychopathology. J Clin Psychiatry. 67:1441,2006.

21. DelBello, MP:  To medicate or not to medicate?  J Clin Psychiatry  68: 1087, 2007.

22. DelBello MP: Can research inform the clinical care of mental health disorders in children and adolescents? J Clin Psychiatry. 68:296, 2007.

23. DelBello MP: An ounce of prevention is worth a pound of cure. J Clin Psychiatry. 68: 766, 2007.

24. Barzman DH, DelBello MP: Effects of topiramate – Drs. Barzman and DelBello reply. Am J Psychiatry. 164: 527-528, 2007.

25. Fleck DE, Arndt S, DelBello MP, Strakowski SM: Reply to Drs. Fossey, Allen and Yates regarding: Concurrent tracking of alcohol use and bipolar disorder symptoms.  Bipolar Disord, 9: 790-791, 2007.

26. DelBello, MP: Are girls and boys from different planets?  J Clin Psychiatry. 68:1563-1564, 2007.

27. DelBello, MP: The phenomenology and assessment of childhood and adolescent mental health: Progress in research. J Clin Psychiatry. 68:1418, 2007. 

28. DelBello, MP: Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic

      approaches.  J Clin Psychiatry, 69:130, 2008. 

29. DelBello MP: Mood disorders: assessment, risk factors, and outcome. J Clin Psychiatry 69:830, 2008.

222222

Abstracts and Presentations:

1998

  1. Sax KW, Zimmerman ME, DelBello MP, Hawkins JM, Keck PE, Jr, Strakowski SM: Prefrontacortical volume and attentional functioning in mania. Biol Psychiatry 1998, 41:16S.
  2. DelBello MP, Strakowski SM, Sax KW, Zimmerman ME, Hawkins JM: MRI analysis of the cerebellum in bipolar disorder. Biol Psychiatry 1998, 41:16S.
  3. DelBello MP, Strakowski SM, Sax KW, Zimmerman ME, Hawkins JM: MRI analysis of the cerebellum in bipolar disorder.  Research Colloquium for Junior Investigators, American Psychiatric Association Annual Meeting, Toronto, Canada, May 31-June 4, 1998.
  4. Strakowski SM, DelBello MP, Saw KW, Zimmerman ME, Hawkins JM: MRI brain morphometry in bipolar disorder.  American Psychiatric Association Annual Meeting, Toronto, Canada, May 30-June 4, 1998.

1999

  1. DelBello MP, Soutullo CA, Zimmerman ME, Sax KW, McElroy SL, Strakowski SM: Head injury in sex offenders with and without bipolar disorder.  J Neuropsychiatry Clin Neurosci 11:149, 1999.
  2. Fleck D, DelBello MP, Zimmerman ME, Sax KW, Strakowski SM: Cerebellar correlates of the Stroop Color Word Test and Continuous Performance Test in healthy volunteers.  J Neuropsychiatry Clin Neurosci 11: 153, 1999.
  3. DelBello MP, Zimmerman ME, Fleck DE, Sax KW, Strakowski SM: Structural MRI comparison of schizophrenia and bipolar disorder. Biol Psychiatry 42: 75S, 1999.
  4. DelBello MP, Rizzo MP, Getz GE, Sax KW, Strakowski SM: Treatment of schizoaffective disorder with divalproex sodium. Biol Psychiatry 42: 129S, 1999.
  5. Soutullo CA, DelBello MP, Casuto LS, Lake K, Graman SM, McDonough-Ryan P, McElroy SL, Strakowski SM, Keck PE: Psychiatric disorders in children of bipolar parents versus controls: preliminary results.  American Psychiatric Association Annual Meeting, Washington, DC, May, 1999.
  6. DelBello MP, Soutullo CA, Ochsner JE, McElroy SL, Keck PE, Strakowski SM: Racial differences in the treatment of adolescents with bipolar disorder. American Psychiatric Association Annual Meeting, Washington, DC, May, 1999.
  7. DelBello MP, Soutullo CA, Zimmerman ME, Ryan P, Graman S, McElroy SL, Strakowski SM: MRI analysis of children at risk for bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, Chicago, IL; October, 1999.
  8. DelBello MP, Soutullo CA, McDonough-Ryan P, Graman S, Neimeier RT, Lake K, McElroy SL, Strakowski SM: Obstetrical complications in children at risk for bipolar disorder. 1999 American Academy of Child and Adolescent Psychiatry Annual Meeting, Chicago, IL; October, 1999.
  9. Strakowski SM, Rosenberg HL, DelBello MP, Sax KW: Behavioral sensitization in humans: results of a parallel-group, double-blind study. ACNP Annual Meeting, Acapulco, Mexico, 1999.
  10. DelBello MP, Zimmerman ME, Fleck DE, Sax KW, Strakowski SM:  Structural MRI comparison of schizophrenia and bipolar disorder.  Biological Psychiatry, 45: 192S, 1999.

2000

  1. DelBello MP, McDonough-Ryan P, Soutullo CA, Graman SM, Zimmerman ME, Getz GE, Strakowski SM: MRI analysis of children at risk for bipolar disorder. Bipolar Disorder: From reclinical to Clinical, Facing the New Millennium. Phoenix, Arizona, January, 2000.
  2. Strakowski SM, Williams JR, Sax KW, Fleck DE, DelBello MP, Bourne ML: Mood-incongruent psychosis and short-term outcome following hospitalization for first-episode mania. 2nd Annual International Early Psychosis Association Meeting, New York, NY.
  3. Lopez-Larson, MP, DelBello MP, Steed M, Strakowski SM: MRI analysis of cortical grey and white matter in patients with bipolar disorder. American Psychiatric Association Annual Meeting, Chicago, IL, May, 2000.
  4. DelBello MP, McDonough-Ryan, P, Graman SM, Soutullo CA, Zimmerman ME, Rosenberg HL, Strakowski SM: MRI analysis of the cerebellum in children at risk for bipolar disorder. American Psychiatric Association Annual Meeting, Chicago, IL, May, 2000.
  5. Graman SM, Lake KA, DelBello MP, McDonough-Ryan P, Soutullo CA, McElroy SM, Strakowski SM: Assessing children at risk for bipolar disorder using the Child Behavior Checklist (CBCL). American Psychiatric Association Annual Meeting, Chicago, IL, May, 2000.
  6. Strakowski SM, DelBello MP, Wigh W, Brock AM, Fleck DE: Courses of co-occurring bipolar and alcohol use disorders, In: symposium, “Bipolar illness and alcohol abuse: course and treatment.” American Psychiatric Association Annual Meeting, Chicago, IL, May, 2000.
  7. DelBello MP, Soutullo CA, McDonough-Ryan, P, Graman SM, Zimmerman ME, Getz GE, Lake KA, Strakowski SM: MRI analysis of children at risk for bipolar disorder. Biol Psychiatry, 47:13S, 2000.
  8. DelBello MP, Strakowski SM, Sax KW, McElroy SL, Keck PE, Jr, Kmetz GF: Familial rates of affective and substance use disorders in patients with first episode mania.  Research Colloquium for Junior Investigators, American Psychiatric Association Annual Meeting, Chicago, IL, May, 2000
  9. McDonough-Ryan P, Shear P, Ris D, DelBello MP, Graman SM, Rosenberg HL, Strakowski SM: IQ and academic achievement in children of bipolar patients. Clinical Neuropsychol 14:248, 2000.
  10. Soutullo CA, DelBello MP, Mcdonough-Ryan P, Pereda T, McElroy SL, Strakowski SM: Early manic and depressive symptoms in children of bipolar parents vs. controls. American Academy of Child and Adolescent Psychiatry Annual Meeting, New York, New York, October, 2000.
  11. Soutullo CA, DelBello MP, Ochsner JE, McElroy SL, Taylor S, Keck PE Jr: Severity of  bipolar illness in hospitalized manic adolescents exposed to stimulants or antidepressants. Spanish Psychiatric Society 5th Congress, October 19, 2000, Zaragoza, Spain. Poster 32.
  12. Soutullo CA, DelBello MP, McDonough-Ryan P, Lake K, Pereda T, McElroy S. Early mood symptoms in children of bipolar parents vs. controls. Spanish Psychiatric Society 5th Congress, October, 2000, Zaragoza, Spain, Poster 33.
  13. Strakowski SM, Williams JR, Sax KW, Fleck DE, DelBello MP, Bourne ML Mood-incongruent psychosis and short-term outcome following hospitalization for first-episode mania.  Presented at the 2nd Annual International Early Psychosis Association Meet, New York, NY, March, 2000.
  14. Strakowski SM, DelBello MP, Wigh WL, Brock AM, Fleck DE:  Courses of co-occurring bipolar and alcohol use disorders.  Presented at the 153rd Annual Meeting of the American Psychiatric Association, Chicago, IL. May, 2000. 

2001

  1. McDonough-Ryan P, Shear PK, DelBello MP, Ris D, Strakowski SM:  Academic and cognitive abilities in children of parents with bipolar disorder: a test on the nonverbal learning disability model. International Neuropsychological Society, Chicago, IL, February, 2001.
  2. DelBello MP, Zimmerman ME, Getz GE, Strakowski SM: MRI analysis of adolescents with bipolar disorder, Biol Psychiatry, 49:20S, 2001.
  3. Adler CM, Strakowksi SM, Holland SK, Schmithorst V, DelBello MP, Tuchfarber MJ: Neurophysiology of working memory in bipolar disorder: an fMRI study. Biol Psychiatry, 49:44S, 2001.
  4. Strakowski SM, Adler CM, Holland SK, DelBello MP, Schmithorst V: Neural activation during facial affect recognition in euthymic bipolar disorder. Biol Psychiatry, 49:81S, 2001.
  5. Lopez-Larson M, DelBello MP, Zimmerman ME, Strakowski SM: MRI characterization of frontal subregions in patients with bipolar disorder, American Psychiatric Association Annual Meeting, New Orleans, LA, May, 2001.
  6. Soutullo CA, DelBello MP, Mcdonough-Ryan P, Pereda T, McElroy SL, Strakowski SM: Early symptoms in children of bipolar parents vs. controls, American Psychiatric Association Annual Meeting, New Orleans, LA, May, 2001.
  7. Cecil KM, Ball WS, DelBello MP, Strakowski SM: Orbital frontal metabolite changes in bipolar disorder: A Proton magnetic resonance spectroscopy study. Bipolar Disord, 3 Suppl 1:30, 2001.
  8. DelBello MP, Rosenberg HL, Hudepohl AM, Strakowski SM: Quetiapine as adjunctive treatment for adolescent mania. Bipolar Disord, 3 Suppl 1:33, 2001.
  9. McDonough-Ryan P, DelBello MP, Shear PK, Ris MD, Strakowski SM: Neuropsychological functioning in children of parents with bipolar disorder. American Psychological Association Annual Convention, San Francisco, CA, August, 2001.
  10. Kowatch RA, DelBello MP, Wilke M, McConville BJ: fMRI study of affect recognition in bipolar children and controls, American Academy of Child and Adolescent Psychiatry Annual Meeting, Honolulu, Hawaii, October, 2001.
  11. DelBello MP, Cecil KM, Soutullo CA, McDonough-Ryan P, Schwiers ML, Strakowski SM: Neurobiological characterization of children at risk for bipolar disorder, American Academy of Child and Adolescent Psychiatry Annual Meeting, Honolulu, Hawaii, October, 2001.
  12. DelBello MP, Rosenberg HL, Shear PK, Schwiers ML, Strakowski SM: Quetiapine for the treatment of adolescent mania, American Academy of Child and Adolescent Psychiatry Annual Meeting, Honolulu, Hawaii, October, 2001.
  13. DelBello MP, Kowatch RA, Warner J, Rappaport K, Daniels J, Foster KD, Nelson D, Strakowski SM: Topiramate treatment for pediatric bipolar disorder: a retrospective chart review, American Psychiatric Association, Institute on Psychiatric Services, Orlando, FL, October, 2001.
  14. DelBello MP, Rosenberg HL, Wilhoit SR, Seshadri V, Strakowski SM: Safety, tolerability and efficacy of quetiapine as adjunctive treatment for bipolar adolescents with mania, American Psychiatric Association, Institute on Psychiatric Services, Orlando, FL, October, 2001.
  15. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM: Quetiapine as adjunctive treatment for adolescent mania. American College of Neuropsychopharmacology, December, 2001.
  16. DelBello MP, Zimmerman ME, Getz GE, Strakowski SM:  MRI analysis of structural neuroanatomic abnormalities in adolescents with bipolar disorder. American College of Neuropsychopharmaology, December, 2001.
  17. DelBello MP, Getz GE, Fleck DE, Zimmerman ME, Strakowski SM: Neuroanatomic characterization of schizoaffective disorder using magnetic resonance imaging (MRI).  Schizophrenia Res, 49:1-2S, 2001.

 

                                   2002

  1. Shear PK, DelBello MP, Rosenberg HL, Strakowski SM: Parent ratings of executive functioning in adolescents with bipolar disorder.  International Neuropsychological Society Annual Meeting, Toronto, Canada, February, 2002.
  2. Rosenberg HL, Sax KW, DelBello MP, Adler CM, Shear PK, Strakowski SM: Cognitive effects of d-amphetamine exposure.  International Neuropsychological Society Annual Meeting, Toronto, Canada, February, 2002.
  3. Jak A, Shear PK, Zimmerman ME, Getz GE, DelBello MP, Strakowski SM: Brain structural correlates of memory in bipolar disorder. International Neuropsychological Society Annual Meeting, Toronto, Canada, February, 2002.
  4. DelBello MP, Kowatch RA, Warner J, Rappaport K, Daniels J, Foster KD, Nelson D, Strakowski SM: Topiramate treatment for pediatric bipolar disorder: a retrospective chart review.  Society of Biological Psychiatry Annual Meeting, Philadelphia, PA, May, 2002.
  5. DelBello MP, Kowatch RA, Warner J, Rappaport K, Daniels J, Foster KD, Nelson D, Strakowski SM: Topiramate treatment for pediatric bipolar disorder: a retrospective chart review.  American Psychiatric Association Annual Meeting, Philadelphia, PA, May 18-23, 2002.
  6. Fleck DE, Henricks, WL, DelBello MP, Strakowski SM: Ethnic differences in antipsychotic use following bipolar disorder onset.  American Psychiatric Association Annual Meeting, Philadelphia, PA, May, 2002.
  7. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM: Quetiapine as adjunctive treatment for adolescent mania. College of Psychiatric and Neurologic Pharmacists Annual Meeting, April, 2002.
  8. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM: Quetiapine as adjunctive treatment for adolescent mania.  Collegium Internationale Neuro-Psychopharmacologium, Montreal, Canada, June, 2002.
  9. DelBello MP, Adler CM, Mills NP, Kowatch RA, Strakowski SM.  FMRI study of the Continuous Performance Test in bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, San Francisco, CA, October, 2002.
  10. DelBello MP, Miller AN, Warner J, Rosenberg HL, Strakowski SM: Olanzapine treatment   for adolescent bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, San Francisco, CA, October, 2002.
  11. Kowatch RA, Wilke M, Mills NP, DelBello MP, Holland SK, Strakowski SM: An fMRI study of affect discrimination in bipolar children and normal controls.  American Academy of Child and Adolescent Psychiatry Annual Meeting, San Francisco, CA, October 2002.
  12. DelBello MP, Adler CM, Mills NP, Holland SK, Strakowski SM: fMRI study of the Continuous Performance Test in unmedicated manic adolescents with bipolar disorder.  American College of Neuropsychopharmacology Annual Meeting, Puerto Rico, December, 2002.
  13. Jak AJ, Shear PK, Rosenberg HL, DelBello MP, Strakowski SM: Intellectual functioning in children with bipolar disorder.  American Psychological Association Annual Meeting, Chicago, IL, August, 2002.

                       

2003

  1. DelBello MP: Novel treatments for pediatric bipolar disorder. American Psychiatric Association Annual Meeting, San Francisco, CA, May, 2003.
  2. Jak A, Shear PK, DelBello MP, Rosenberg HL, Strakowski SM: Verbal learning and memory in children with bipolar disorder. International Neuropsychological Society Annual Meeting, Honolulu, HI, February 2003. 
  3. Zimmerman ME, Shear PK, DelBello MP, Getz GE, Schwiers ML, Strakowski SM:  Executive functioning correlates of anterior cingulate subregion volumes in bipolar disorder. International Neuropsychological Society Annual Meeting, Honolulu, HI, February 2003. 
  4. Getz GE, Fleck DE, Zimmerman ME, Schwiers, DelBello MP, Strakowski SM: Reduced superior temporal gyrus volumes in bipolar disorder.  American Neuropsychiatric Association Annual Meeting, February, 2003.
  5. DelBello MP, Adler CM, Schwiers M, Rosenberg HL, Strakowski SM: Divalproex for the treatment of aggression associated with adolescent mania.  International Conference on Bipolar Disorders, Pittsburgh. PA, June, 2003.
  6. DelBello MP, Kowatch RA, Cecil KM, Mills N, Holland S, Strakowski SM: The neuropathophysiology of adolescent bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, Miami, FL, October, 2003.
  7. DelBello MP, Kowatch RA, Schwiers M, Strakowski SM: Psychopharmacology of pediatric bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, Miami, FL, October, 2003.
  8. DelBello MP, Carlson G, Tohen M, Bromet E, Schwiers M, Strakowski SM: First-episode major depression with psychosis and developing mania.  American Academy of Child and Adolescent Psychiatry Annual Meeting, Miami, FL, October, 2003.
  9. DelBello MP, Kowatch RA, Warner J, Rofey D, Rappaport K, Daniels J, Foster K, Strakowski SM: Adjunctive topiramate in pediatric bipolar patients hospitalized for an acute manic episode: A retrospective chart review. American Academy of Child and Adolescent Psychiatry Annual Meeting, Miami, FL, October, 2003.
  10. Soutullo CA, DelBello MP, McDonough-Ryan P, McElroy S, Strakowski SM, Keck PE: Phenomenology in bipolar offspring vs. controls: factor and receiving operating characteristics (ROC) analyses.  American Academy of Child and Adolescent Psychiatry Annual Meeting, Miami, FL, October, 2003.
  11. DelBello MP, Kushner S, Wang D, Olson W, Capece J, Fazzio L, Rosenthal N: Topiramate treatment for acute mania in adolescents with bipolar I disorder.  American College of Neuropsychopharmacology Annual Meeting, Puerto Rico, December, 2003.
  12. DelBello MP, Cecil KM, Warner J, Adler CM, Strakowski SM:  Neurochemical effects and predictors of response to pharmacological treatments for adolescent bipolar disorder. American College of Neuropsychopharmacology Annual Meeting, Puerto Rico, December, 2003 (Chair- Panel Session).
  13. Adler C, Holland S, DelBello M, Strakowski SM: Depressive episode related changes in cognition and neuronal activation. American College of Neuropsychopharmacology Annual Meeting, Puerto Rico, December, 2003.
  14. Cecil KM, Ball WS, DelBello MP, Strakowski SM: Orbital frontal metabolite changes in bipolar disorder: A proton magnetic resonance spectroscopy study. Cincinnati Translational Neuroscience Symposium, March, 2003.
  15. Cecil KM, DelBello MP, Strakowski SM: Children with a mood disorder and a familial risk for bipolar disorder demonstrate significant neurochemical differences observed with MR Spectroscopy.  41st Annual Meeting, American Society of Neuroradiology, Washington, DC, April, 2003.
  16. DelBello MP, Mills NP, Adler CM, Strakowski SM: Functional MRI analysis of
    attention in adolescents with bipolar disorder. NIMH Pediatric Bipolar Disorder Conference, Boston, Massachusetts, March, 2003.
  17. Getz GE, Fleck DE, Zimmerman ME, Schwiers ML, DelBello MP, Strakowski SM:  Reduced superior temporal gyrus volumes in bipolar disorder. Neuropsychiatry Clin Neurosciences, 15: 2003.

                                   2004

  1. Adams JN, Adler CM, DelBello MP, Mills NP, Strakowski SM: Quantitative measures of white- matter diffusivity in manic adolescents.  American Psychiatric Association Annual Meeting, New York, NY, May, 2004.
  2. DelBello MP, Barzman D, Kowatch RA, Gernert EH, Rappaport KB, Delgado S, Pathak S:      Aripiprazole for pediatric bipolar disorder: A retrospective chart review. American Psychiatric        Association Annual Meeting, New York, NY, May, 2004.
  3. DelBello MP, Kushner S, Wang D, Olson W, Capece J, Fazzio L, Rosenthal N:  Topiramate for acute mania in adolescent patients with bipolar I disorder.  American Psychiatric Association Annual Meeting, New York, NY, May, 2004.
  4. Shear PK, DelBello MP, Rosenberg HL, Jak AJ, Strakowski SM: Cognitive functioning in       manic adolescents with bipolar disorder: contribution of comorbid ADHD. International        Neuropsychological Society Annual Meeting, Baltimore, MD, February, 2004.
  5. Soutullo Esperón C, Díez Suárez A, DelBello MP, McDonough-Ryan P, McElroy SL, Strakowski SM, Keck, PE Jr.: Fenomenología en hijos de pacientes con enfermedad bipolar frente a controles. 40th Annual Meeting Spanish Association of Child and Adolescent Psychiatry. Lérida, Spain 5 June 2004. Revista de Psiquiatría Infanto-Juvenil, 2004.
  6. DelBello MP, Fazzio LO, Kushner SF, Bryan H, Wang D, Olson WH, Capece JA, Rosenthal NR: Topiramate for acute mania in children and adolescents with bipolar I disorder, American Psychiatric Association 56th Institute on Psychiatric Services (APA-IPS), Atlanta, GA, October,  2004.
  7.   DelBello MP, Kowatch RA, Adler CM, Strakowski SM: Atypical antipsychotics for the treatment of pediatric bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, Washington, D.C, October, 2004.
  8. DelBello MP, Adler CM, Eliassen JC, Mills NP, Strakowski SM: Anterior limbic dysfunction in adolescent bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting Washington, D.C, October, 2004.
  9. DelBello MP, Kowatch RA, Adler CM, Barzman D, Strakowski SM: A double-blind comparison of divalproex versus quetiapine for adolescent mania. American Academy of Child and Adolescent Psychiatry Annual Meeting, Washington, D.C., October, 2004.
  10. DelBello MP, Kowatch R, Barzman D, Strakowski SM: Impulsivity and aggression: assessment and treatment of comorbid psychiatric disorders. American Academy of Child and Adolescent Psychiatry Annual Meeting, Washington, D.C., October, 2004.
  11. DelBello MP, Findling R, Kushner S, Wang D, Olson W, Capece J, Fazzio L, Rosenthal N:       Topiramate treatment for acute bipolar mania in children and adolescents.  American Academy       of Child and Adolescent Psychiatry Annual Meeting, Washington, D.C., October, 2004.
  12. Adams J, Adler C, DelBello MP, Mills N, Strakowski SM: Quantitative measures of white       matter diffusivity in manic adolescents.  American Academy of Child and Adolescent Psychiatry Annual Meeting, Washington, D.C., October, 2004.
  13. DelBello MP, Kowatch RA, Adler CM, Welge JA, Strakowski SM: A double-blind comparison  of divalproex versus quetiapine for adolescent mania. Neuropsychopharmacology 29: Suppl 1: 98, 2004.
  14. Barzman DH, DelBello MP, Fleck DE, Lehmkuhl H, Strakowski SM.  Risk factors for juvenile       offending before treatment for bipolar disorder.  Presented at the 51st Annual Meeting of the       American Academy of Child and Adolescent Psychiatry, Washington, D.C, October, 2004.

 

                                   2005

  1. Jak A, Shear PK, DelBello MP, McDonnough-Ryan P and Strakowski SM:  Frontal lobe       morphometry and executive functioning in children at risk for bipolar disorder. International       Neuropsychological Society Annual Meeting, St. Louis, Missouri, February, 2005.
  2. Foster MK, Shear PK, DelBello MP, Houterloot EP and Strakowski SM:Reports of executive       dysfunction in adolescents at genetic risk for bipolar disorder. International Neuropsychological Society Annual Meeting, St. Louis, Missouri, February, 2005.
  3. Warner J, DelBello MP, Shear PK, Fleck DE and Strakowski SM: Executive functioning deficits in youth with comorbid bipolar disorder +ADHD:  Are they additive? International       Neuropsychological Society Annual Meeting, St. Louis, Missouri, February, 2005.
  4. Hunziker, ME, Patel NC, Crismon L, DelBello MP, Shafer A: Symptom profiles of prepubertal children with a diagnosis of ADHD, bipolar disorder, or a depressive disorder. College of Psychiatric and Neurologic Pharmacists Annual Meeting. San Diego, California, March, 2005.
  5. DelBello MP, Cecil KM, Adler CM, Kowatch RA, Strakowski SM: Neuropharmacological       studies of adolescent bipolar disorder. NIMH Pediatric Bipolar Disorder Conference, Miami, Florida, April, 2005.
  6. Cecil KM, DelBello MP, Adler CM, Daniels J. Strakowski SM: Neurochemical effects of     olanzapine in adolescent mania: A proton magnetic resonance spectroscopy study, International Society for Magnetic Resonance in Medicine, 13th Scientific Meeting and Exhibition, Miami, FL, May, 2005, 1193.
  7. DelBello MP: Bipolar disorder from adolescence to adulthood. American Psychiatric       Association Annual Meeting, Atlanta, Georgia, May, 2005.
  8. DelBello MP, Adler CM, Stanford KE, Kowatch RA, Strakowski SM: Quetiapine efficacy in bipolar adolescents with depression. American Psychiatric Association Annual Meeting, Atlanta, Georgia, May, 2005.
  9. Adler CM, DelBello MP, Holland SK, Schmithorst V, Mills N, Strakowski S: Functional MRI        investigation of ADHD comorbidity in bipolar adolescents performing a simple attention task.        Annual Meeting of the International Society for Magnetic Resonance in Medicine, Miami, Florida, May, 2005
  10. Adler CM, Adams J, DelBello MP, Holland SK, Schmithorst V, Levine A, Jarvis K, Strakowski  S: Evidence of white matter pathology in first-episode manic adolescents with bipolar disorder:A diffusion tensor imaging study. Annual Meeting of the International Society for Magnetic Resonance in Medicine, Miami, Florida, May, 2005
  11. Patel NC, DelBello MP, Strakowski SM. Ethnic differences in symptom presentation of adolescents with bipolar disorder.  44th Annual New Clinical Drug Evaluation Unit Meeting, Boca Raton, Florida, June, 2005.
  12. DelBello MP: Treatment of depression associated with bipolar disorder in adolescents.        American Academy of Child and Adolescent Psychiatry Annual Meeting, Toronto, Ontario,        Canada October, 2005.
  13. Cecil KM, DelBello MP, Adler C, Daniels J, Strakowski SM: Neurochemical effects of olanzapine in adolescent mania: A proton magnetic resonance spectroscopy study. International  Society for Magnetic Resonance in Medicine Workshop, MR Spectroscopy of Neuropsychiatric Disorders, Banff, Alberta, Canada, October, 2005.
  14. DelBello MP: Atypical antipsychotics for adolescents at risk for bipolar disorder. American     Academy of Child and Adolescent Psychiatry Annual Meeting, Toronto, Ontario, Canada, October, 2005.
  15. Barzman DH, DelBello MP, Stanford K, Kowatch RA, Adler C, Strakowski SM: Treatment for aggression in bipolar adolescents with disruptive behavioral disorders. American Academy of Child and Adolescent Psychiatry Annual Meeting, Toronto, Ontario, Canada, October, 2005.
  16. Patel NC, DelBello MP, Bryan H, Adler CM, Kowatch RA, Stanford K, Strakowski SM: Open-label lithium for the treatment of adolescent bipolar depression. American Academy of Child and Adolescent Psychiatry Annual Meeting, Toronto, Ontario, Canada, October, 2005.
  17. DelBello MP, Kowatch RA, Stanford K, Adler CM, Welge J, Strakowski SM: Quetiapine           efficacy in bipolar adolescents with depressive symptoms. American Academy of Child and           Adolescent Psychiatry Annual Meeting, Toronto, Ontario, Canada, October, 2005.
  18. DelBello MP, Ice K, Keller D, Versavel M, Miceli J: Ziprasidone dosing study in pediatric           bipolar and schizophrenic subjects. American Academy of Child and Adolescent Psychiatry           Annual Meeting, Toronto, Ontario, Canada, October, 2005.
  19. Giles L, DelBello MP, Stanford K, Strakowski SM: Child Behavior Checklist profile of youth at risk for bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, Toronto, Ontario, Canada, October, 2005.
  20. Singh MK, DelBello MP, Stanford K, McDonough-Ryan P, Soutullo C, Strakowski SM: Neuroanatomic characterization of child offspring of bipolar parents. American Academy of           Child and Adolescent Psychiatry Annual Meeting, Toronto, Ontario, Canada October, 2005.
  21. Cecil KM, DelBello MP, Adler CM, Daniels J, Strakowski SM: Olanzapine monotherapy of           mania in adolescents with bipolar disorder: A proton magnetic resonance spectroscopy study.            91st Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL, November, 2005, SSA16-008.
  22. Tohen M, Kryzhanovskaya L, Carlson G, DelBello MP, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Huang X, Dittman R, Biederman J: Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder: A 3-week randomized double-blind placebo-controlled study. Neuropsychopharmacology 30:Suppl 1:176, 2005.
  23. DelBello MP, Adler CM, Eliassen K, Mills N, Strakowski SM: Progression of anterior limbic             dysfunction in adolescent bipolar disorder. Neuropsychopharmacology 30: Suppl 1:33, 2005.
  24. Adler CM, DelBello MP, Levine A, Jarvis K, Adams J, Holland SK, Eliassen J, Strakowski            SM: Complementary morphometric and functional corticolimbic changes in adult bipolar            patients. Neuropsychopharmacology 30:Suppl 1:33, 2005.
  25. Adler CM, Adams J, DelBello MP, Holland SK, Schmithorst V, Levine A, Jarvis K, Strakowski SM: Evidence of white matter pathology in first-episode manic adolescents with bipolar disorder. A diffusion tensor imaging study. Neuropsychopharmacology 30:Suppl 1:93, 2005.
  26. Barzman DH, Adler CM, DelBello MP, Stanford KE, Kowatch RA, Strakowski SM: Quetiapine efficacy in bipolar adolescents with depression. Neuropsychopharmacology  30: Suppl 1:94, 2005.
  27. Versavel M, DelBello MP, Ice K, Kowatch R, Keller D, Miceli J: Ziprasidone dosing study in        pediatric patients with bipolar disorder, schizophrenia, or schizoaffective disorder. Neuropsychopharmacology 30:Suppl 1:122, 2005.
  28. DelBello MP, Cecil KM, Adler CM, Strakowski SM: Prefrontal neurochemical abnormalities             in adolescent bipolar disorder. Neuropsychopharmacology 30:Suppl 1:161, 2005.
  29. Patel NC, DelBello MP, Cecil KM, Bryan HS, Adler CM, Stanford KE, Strakowski SM: Proton magnetic resonance spectroscopy study of the effects of lithium in myo-inositol in bipolar depressed adolescents. Neuropsychopharmacology 30: Suppl 1:187, 2005.
  30. Strakowski SM, DelBello MP, Kowatch RA, Whitsel R, Adler CM: A single-blind prospective study of quetiapine for the treatment of mood disorders in adolescents who are at high risk for developing bipolar disorder. Neuropsychopharmacology 30:Suppl 1:240, 2005.
  31. DelBello MP, Kowatch R, Stanford KE, Adler CM, Welge JA, Barzman D, Strakowski SM: Quetiapine compared with divalproex monotherapy in adolescent mania. Bipolar Disord: Suppl 2:45, 2005.
  32. DelBello MP, Adler CM, Barzman D, Strakowski SM: Quetiapine efficacy in bipolar            adolescents with depressive symptoms. Bipolar Disord 7:Suppl 2:46, 2005.
  33. Barzman DH, DelBello MP, Lehmkuhl H, Fleck DE, Strakowski SM: The identification of            risk and protective factors for offending behaviors in bipolar adolescents.  Presented at the 36th           Annual Meeting of the American Academy of Psychiatry and the Law, Montreal, Quebec, October, 2005.

2006

  1. Chu W-J, Strakowski SM, Hetherington HP, Wang X, Adler CM, DelBello MP, Adams JN, Mills NP, Jarvis KB, Lee JH: Hippocampal neurochemical findings in medication-free           euthymic bipolar disorder. 1H MRSI study.  International Society for Magnetic Resonance in Medicine.
  2. Chu W-J, Strakowski SM, Hetherington HP, DelBello MP, Adler CM, Lee JH: Regional T1            relaxation time and tissue content changes of hippocampus in bipolar disorder. International Society for Magnetic Resonance in Medicine.
  3. Leckinger M, Patel NC, Matias-Akthar M, Sorter MT, Barzman DH, Klein DJ, Morrison JA, Strakowski SM, DelBello MP. Lipid profiles of youths treated with antipsychotics: a retrospective cross-sectional evaluation. American Psychiatric Association Annual Meeting, Toronto, Canada, May 2006.
  4. Patrick D, Patel NC, DelBello MP, Strakowski SM. A preliminary study of relationships between the Young Mania Rating Scale and Clinical Global Impressions Scale in adolescents with bipolar disorder. American Psychiatric Association Annual Meeting, Toronto, Canada, May 2006.
  5. DelBello MP:  Evidence-based treatment of children and adolescents with bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, California, October 2006.
  6. DelBello MP, Adler CM, Strakowski SM:  Treatment of youth with and at risk for bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, California, October 2006.
  7. DelBello MP, Adler CM, Eliassen J, Jarvis K, Mills N, Strakowski SM:  Neurophysiological predictors of substance use disorders (SUD) in bipolar adolescents:  American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, California, October 2006.
  8. Nandagopal JJ, DelBello MP, Stanford K, Mills N, Amicone J, Strakowski S:  Impulsivity in            adolescents with bipolar disorder and ADHD. American Academy of Child and Adolescent            Psychiatry Annual Meeting, San Diego, California, October 2006.
  9. Barzman DH, DelBello M, Forrester J, Keck P Jr, Strakowski S: Intramuscular ziprasidone for            acute agitation in children and adolescents. American Academy of Child and Adolescent            Psychiatry Annual Meeting, San Diego, California, October 2006.
  10. DelBello MP, Whitsel RM, Adler CM, Kowatch RA, Stanford K, Strakowski SM:  Quetiapine            efficacy in adolescents with mood disorders and a family history of bipolar disorder. American            Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, California, October, 2006.
  11. Robertson-Plouch C, Tohen M, Kryzhanovskaya L, Carlson G, DelBello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Xu W, Dittmann R, Biederman J:  Olanzapine versus placebo in adolescent mania. American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, California, October 2006.
  12. Singh MK, Fleck D, DelBello M, Shear P, Strakowski SM: Attentional dysfunction in child             offspring of bipolar parents: A preliminary report. American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, California, October 2006.
  13. Giles LL, DelBello M, Gilbert D, Stanford K, Shear P, Strakowski SM: Cerebellar ataxia in             youth at risk for bipolar disorder.  American Academy of Child and Adolescent Psychiatry             Annual Meeting, San Diego, California, October 2006.
  14. DelBello MP, Stewart M, Versavel M, Keller D, Miceli J: Psychosocial functioning in             psychotic youth treated with open-label ziprasidone. American Academy of Child and             Adolescent Psychiatry Annual Meeting, San Diego, California, October 2006.
  15. Patel NC, DelBello MP, Cecil KM, Adler CM, Bryan HS, Stanford KE, Strakowski SM: A             proton magnetic resonance spectroscopy study of the effects of lithium on myo-inositol in             bipolar depressed adolescents. 9th Annual International Meeting of the College of Psychiatric and Neurologic Pharmacists, 2006.
  16. Chu W-J, Strakowski SM, Hetherington HP, Wang X, Adler CM, DelBello MP, Adams JN, Mills NP, Gao Y, Jarvis JH: Hippocampal neurochemical findings in medication-free, euthymic bipolar disorder: 1H MRSI study. International Society for Magnetic Resonance in Medicine Annual Meeting, Seattle, Washington, 2006.
  17. Chu W-J, Strakowski SM, Hetherington HP, DelBello MP, Adler CM, Lee JH: Regional T1              relaxation time and tissue content changes of hippocampus in bipolar disorder. International Society for Magnetic Resonance in Medicine Annual Meeting, Seattle, Washington, 2006.
  18. Allendorfer JB, Lamy M, Eliassen JG, Adams J, Mills NP, Adler GM, DelBello MP, Lee JH, Fleck DE, Strakowski SM: Attentional and emotional networks differ in manic bipolars          compared to healthy controls.  Presented at the 36th Annual Meeting of the Society for          Neuroscience, Atlanta, GA, October, 2006. 
  19. DelBello, MP, Whitsel RM, Adler CM, Kowatch RA, Stanford KE, Strakowski SM:  A single-blind prospective study of quetiapine for the treatment of mood disorders in adolescents at high risk for developing bipolar disorder.  American Psychiatric Association Annual Meeting, Toronto, Canada, 2006.
  20. Lamy M, Allendorfer JB, Cerullo M, Eliassen JC, Adams J, Mills NP, Adler CM, DelBello MP, Lee J, Strakowski SM:  Pregenual anterior cingulated cortex activation correlates with socioeconomic status in bipolar disorder.  26th Annual Meeting of the Society for Neuroscience, Atlanta, Georgia, 2006.
  21. Adler CM, DelBello MP, Jarvis KB, Eliassen JC, Mills NP, Strakowski SM: Neuroimaging correlates of substance use disorders in bipolar adolescents.  American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, California, 2006.

2007

145   Kramer ME, Epstein JN, Mills NP, Altaye A, Adler CM, Strakowski SM, DelBello MP.             Performance of ADHD adolescents and normal controls on a parametric continuous performance test (CPT). 35th Annual Meeting of the International Neuropsychological Society, Portland, Oregon, Feb, 2007.

  1. Kryzhanovskaya L, Carlson G, DelBello MP, Findling R, Kowatch R, Schulz, SC, Robertson-Plouch C, Xu W, Sethurman G, Carlson J, Tohen M: Changes in metabolic  parameters in adolescents with schizophrenia or bipolar I disorder during treatment with  olanzapine: A pooled analysis of 4 studies. International Congress on Schizophrenia Research, Colorado Springs, Colorado, 2007
  2. Birmaher B, Leibenluft E, Brotman MA, Guyer AE, Rich BA, Dickstein DP, Axelson DA,             Pine DS, DelBello MP, Ladouceur CD, Phillips ML: Altered processing of emotional stimuli:             Endophenotype for bipolar disorder? Biol Psychiatry 61:181 Suppl: 586, 2007.
  3. Youngstrom EA, Joseph MF, Soares JC, Chang KD, Fristad MA, Leibenluft E, DelBello MP, Kowatch RA, Findling RL, Carlson GA, Wozniak J, Frazier JA, Scheffer RE: Young Mania              Rating Scale scores across twelve research groups. American Academy of Child and              Adolescent Psychiatry Annual Meeting, Boston, Massachusetts, October, 2007.
  4. Xu WI, Tohen M, Wozniak J, Lin D, Dittman RW, DelBello MP, Kowatch RA, Wagner KD, Kryzhanovskaya L, Carlson GA, Findling RL, Biederman J: Open-label treatment with              olanzapine in adolescents with bipolar mania. American Academy of Child and Adolescent              Psychiatry Annual Meeting, Boston, Massachusetts, October, 2007.
  5. Pfeifer JC, DelBello MP, Welge JA, Strakowski SM: Meta-analysis of amygdala volumes in              bipolar youth. American Academy of Child and Adolescent Psychiatry Annual Meeting,              Boston, Massachusetts, October, 2007.
  6. DelBello MP, Adler CA, Mills NP, Strakowski SM: Prefrontal neuropharmacology of              adolescent bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual              Meeting, Boston, Massachusetts, October, 2007.
  7. Pandina GJ, DelBello MP, Kushner S, Hove IV, Kusumaker V, Haas M, Augustyns I: Risperidone for the treatment of acute mania in bipolar youth. American Academy of Child and Adolescent Psychiatry Annual Meeting, Boston, Massachusetts, October, 2007.
  8. Redden L, DelBello MP, Wagner KD, Wilens TE, Malhorta S, Wozniak P, Vigna N, Kovacs XI, Greco N, Abi-Saab W., Saltarelli M: Long-tern safety of Divalproex ER in youth with mania. American Academy of Child and Adolescent Psychiatry Annual Meeting, Boston, Massachusetts, October, 2007.
  9. Singh MK, DelBello MP, Strakowski SM: Temperament in child offspring of bipolar parents.         American Academy of Child and Adolescent Psychiatry Annual Meeting, Boston, Massachusetts, October, 2007.
  10. Giles LL, DelBello MP, Mills NP, Gilbert DL, Stanford KE, Shear PK, Strakowski SM: Cerebellar volume and function in children at risk for bipolar disorder. American Academy of Child and Adolescent Psychiatry Annual Meeting, Boston, Massachusetts, October, 2007.
  11. DelBello MP, Adler CM, Mills NP, Strakowski SM: Treatment of co-occurring bipolar and         substance use disorders in adolescents. American Academy of Child and Adolescent Psychiatry Annual Meeting, Boston, Massachusetts, October, 2007.
  12. DelBello MP, Findling RL, Stankowski J, Earley WR, Acevedo LD:  Efficacy of quetiapine in children and adolescents with bipolar mania.  Presented at the 54th Annual Meeting of the         American Academy of Child and Adolescent Psychiatry, Boston, MA, October 2007.
  13. Foster MK, Shear PK, DelBello MP: Perception of emotion in adolescents with bipolar disorder.  Poster presented at the American Psychological Association Meeting, San Francisco, CA, 2007.
  14. Adler CM, DelBello MP, Jarvis KB, Mills NP, Strakowski SM:  Episode-related functional changes in euthymic bipolar patients.  Poster presented at the 44rd Annual Meeting of the American College of Neuropsychopharmacology, Boca Raton, Florida, 2007.
  15. Lamy M, Cerullo MC, Allendorfer JB, Mills NP, Elissen JC, Adler CM, Strakowski SM, DelBello MP:  Differences in brain activation between bipolar and ADHD adolescents in an emotional expression discrimination task.  Presented at the 27th Annual Meeting of the Society for Neuroscience, San Diego, CA, 2007.
  16. McNamara RK, Able J, DelBello MP, Weber WA, Jarvis KB, Strakowski SM, Adler CM: Positive effects of breastfeeding on neuronal integrity and function in boys performing a sustained attention task.  Presented at the 27th Annual Meeting of the Society for Neuroscience, San Diego, California  2007.
  17. Chu W-J, Adler CM, Kim M-J, DelBello MP, Strakowski SM, Lee J-H:  Lactate in bipolar disorder: does it exist and where is it?   Presented at the International Society for Magnetic Resonance in Medicine, 15th Scientific Meeting and Exhibition, Berlin, Germany, 2007.

2008

  1. Kotwal R, Fleck DE, DelBello MP, Strakowski SM:  Functional MRI of impulsivity in the                mixed state of bipolar disorder:  Relationship to suicidal behavior:  Presented at the 161st                 Annual Meeting of the American Psychiatric Association, Washington, D.C., May, 2008.
  2. Fleck DE, Eliassen JC, Adler CM, DelBello MP, Shear PK, Durling M, Cerullo MA, Lamy M, Strakowski SM:  The neurophysiological correlates of sustained attention in bipolar mania.  J Investigative Med, 56: 628-629, 2008.        
  3. DelBello MP, Adler CM, Mills NP, Strakowski SM:  Differential longitudinal neuroimaging of first-episode bipolar vs. ADHD adolescents.  Biol Psychiatry, 63: 50S, 2008.
  4. Adler CM, DelBello MP, Jarvis K, Eliassen JC, Strakowski SM:  Longitudinal structural and functional imaging findings in adult bipolar disorders. Biol Psychiatry, 63: 51S, 2008.  
  5. Adler CM, DelBello MP, Perlis R, Kiki C:  Bipolar disorder in adolescents and adults,       continuum or dichotomy? Biol Psychiatry, 63: 145S, 2008. 
  6. Lamy M, Cerullo MA, Allendorfer JB, Mills NP, Eliassen JC, Strakowski SM, DelBello MP: Alterations of face-responsive visual regions in adolescents bipolar disorder during emotional face processing. Biol Psychiatry, 63:185S, 2008. 
  7. McNamara RK, Able J, Weber W, Jarvis KB, DelBello MP, Strakowski SM, Adler CM: Positive association between breastfeeding duration and neuronal integrity in the dorsolateral prefrontal cortex and anterior cingulated cortex of healthy children: A magnetic resonance spectroscopy study.  Biol Psychiatry, 63:196S, 2008. 
  8. DelBello MP, Findling RL, Wang PP, Gundapaneni B, Versavel M:  Safety and efficacy of       ziprasidone in pediatric bipolar disorder.  Biol Psychiatry, 63: 283S, 2008.
  9. Strawn JR, Adler CM, Fleck DE, Strakowski SM, DelBello MP:  Posttraumatic stress                symptoms in youth with first episode bipolar disorder.  Presented at the 55th Annual                Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, IL.                October 2008.
  10. Nandagopal J, Fleck DE, Strakowski SM, DelBello MP:  Measurement of impulsivity in                adolescents with bipolar disorder and ADHD.  Presented at the 55th Annual Meeting                of the American Academy of Child and Adolescent Psychiatry, Chicago, IL. October, 2008. 
  11. Shear PK, DelBello MP:  Cognitive functioning of children and adolescents with bipolar disorder.  Paper presented at the American Psychiatric Association Meeting, Washington, D.C., 2008.
  12. Long E, Shear PI, DelBello MP:  Emotional processing in youth with bipolar disorder.  Poster accepted for presentation at the International Neuropsychological Society Meeting, Waikoloa, HI, 2008.
  13. Dawson EL, Shear PK, Burciaga J, DelBello MP, Adler CM, Strakowski SM: BRIEF-A responses significantly higher during mixed than manic episodes of bipolar I disorder.  Paper accepted for presentation at the International Neuropsychological Society Meeting, Waikoloa, HI, 2008.
  14. DelBello MP, Adler CM, Fleck DE, Strakowski SM:  Rates and predictors of outcome in first-episode manic bipolar adolescents.  Paper presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL.  October 2008.
  15. DelBello MP:  Neuropharmacology of adolescent bipolar disorder.  Paper presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL.  October 2008.
  16. Findling RL, DelBello MP, Wang, PP, Bachinsky ME, Balarama G, Versavel M:  Long-term safety and tolerability of ziprasidone in children and adolescents with bipolar disorder.  Poster presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL. October 2008.
  17. DelBello MP, Chang K, Howe ME, Bryan HS, Adler CM, Rana M, Welge J, Strakowski SM:  Double-blind placebo controlled study of quetiapine for youth with depression associated with bipolar disorder.  Poster presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL. October 2008.
  18. DelBello MP, Findling RL, Earley W, Stankowski J, Pathak S:  Safety and tolerability of quetiapine in children and adolescents with bipolar I disorder and adolescents with schizophrenia: A 26-week, open label study.  Poster presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL. October 2008.
  19. Barzman D, Sorter MT, Goel A, DelBello MP, Stanford K, Kowatch RA, Saldana SN:  The aggression assessment: A scale for predicting inpatient pediatric aggression.  Poster presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL. October 2008.
  20. Chang K, DelBello MP, Howe ME, Mills NP, Kelley R,  Bryan HS, Adler CM, Rana M, Spielman D, Strakowski SM:  Neurochemical effects of quetiapine in youth with bipolar disorder.  Poster presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL. October 2008.
  21. Nandagopal JJ, Hochadel TJ, Kemper E, Sharoky M, Goodhead ML, DelBello, MP:  A phase IV, double-blind, placebo-controlled, randomized, flexible-dose study of selegiline transdermal system (EMSAM) for the treatment of adolescents with major depression: An interim safety report.  Poster presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL. October 2008.
  22. Kraft EM, Mills NP, Weber WA, Strakowski SM Adler CM, DelBello MP:  Neurobiology of adolescents with bipolar and substance use disorders.  Poster presented at the 55th Annual Meeting of the American Academy of Child and Adolescents Psychiatry, Chicago, IL. October 2008.
  23. Cerullo M, Eliassen J, Adler CM, Lamy M, Henkel D, Strakowski SM, DelBello MP:  Functional connectivity analysis reveals differences in lateral prefrontal connections between pediatric bipolar and ADHD subjects.  Poster presented at the American College of Neuropsychopharmacology Meeting, Scottsdale, Arizona, 2008.
  24. Adler CM, Dietrich K, Lanphear B, Wessel S, Jarvis K, Altaye M, Eliassen J, DelBello MP, Strakowski SM, Cecil K:  Effects of early childhood lead exposure on neuronal function: Evidence of sex-related differences.  Poster presented at the American College of Neuropsychopharmacology Meeting, Scottsdale, Arizona, 2008.
  25. DelBello MP, Adler CM, Eliassen J, Mills NP, Alfieri D, Rue B, Lamy M, Strakowski SM:  Amygdala activation during a parametric task of attention in adolescents with bipolar disorder during mania and euthymia.  Poster presented at the American College of Neuropsychopharmacology Meeting, Scottsdale, Arizona, 2008.
  26. Fleck DE, Eliassen JC, Adler CM, DelBello MP, Shear PK, Durling M, Cerullo MA, Lamy M, Strakowski SM:  Functional MRI of the sustained attention decrement in bipolar mania.  Presented at the 2008 combined Annual Meeting of the Central Society for Clinical Research and the Midwestern Section of the American Federation for Medical Research, Chicago, Illinois, 2008.
  27. McNamara RK, Able J, DelBello MP, Weber WA, Jarvis KB, Strakowski SM, Adler CM:  Chronic docosahexaenoic acid (DHA) treatment increases prefrontal cortex activation during performance of a sustained attention task: a functional magnetic resonance imaging study.  Presented at the Society for Neuroscience, Washington, D.C., 2008

                                               2009

  1. Fleck DE, DelBello MP, Strakowski SM, Anthenelli RM:  Preliminary evidence following hospitalization for first-episode mania in adults and adolescents with bipolar I disorders.  Poster accepted for presentation at The 2009 Joint Conference of SRNT and SRNT-Europe. Dublin, Ireland, 2009.
  2. Fleck DE, Kotwal R, Eliassen JC, Lamy M, DelBello MP, Adler CM, Durling M, Cerrullo MA, Strakowski SM:  Functional MRI of Impulsivity in bipolar depression.  Presented at the Annual Meeting of the Central Society for Clinical Research, Chicago, IL, 2009.
  3. DelBello MP, Nandagopal J, Welge J, Adler CM, Daniels J, Strakowski SM: Topiramate for weight gain in bipolar youth treated with olanzapine. Paper presented at the 56th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu, HI.  October, 2009.
  4. DelBello MP, Adler CM, Mills NP, Eliassen J, Lamy M, Strakowski SM. Treatment of bipolar disorder in adolescents at risk for substance use disorder.  Paper presented at the 56th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu, HI.  October, 2009.
  5. Robinson LA, DelBello MP, Welge JA, Whitsel RM:  Proton magnetic resonance spectroscopy in adolescents with and at-risk for bipolar disorder.  Poster presented at the American Academy of Child and Adolescent Psychiatry, Scientific Proceedings 56th Annual Meeting, Honolulu, HI. October, 2009.
  6. Nandagopal JJ, Patel NC, Adler CM, Strakowski SM, DelBello MP:  Inositol abnormalities in adolescent mania.   Poster presented at the American Academy of Child and Adolescent Psychiatry, Scientific Proceedings 56th Annual Meeting, Honolulu, HI. October, 2009.
  7. DelBello MP.  A double-blind placebo-controlled study of quetiapine for youth with depression associated with bipolar disorder.  Presented at the 49th Annual NCDEU Meeting, Hollywood, Florida, July, 2009.
  8. Cerullo M, Eliassen J, Adler, CM, DelBello MP, Strakowski SM:  Major depressive disorder and bipolar disorder subjects exhibit different functional brain activation during a depressive episode.  Poster presented at the American College of Neuropsychopharmacology Annual Meeting, Hollywood, Florida, December, 2009.
  9. DelBello MP, Bitter S, Mills NP, Adler CM, Strakowski SM:  Progression of amygdala volumetric abnormalities in first-episode manic adolescents.  Poster presented at the American College of Neuropsychopharmacology Annual Meeting, Hollywood, Florida, December, 2009.
  10. Cerullo MA, Eliassen JC, Fleck DE, Adler CM, DelBello MP, Strakowski SM:  The utility of using subjects with unipolar depression as comparison subjects in fMRI studies of bipolar disorder.  Presented at the Central Society for Clinical Research, Chicago, Illinois, 2009.
  11. Chu W-J, Norris MM, Lee J-H, Jarvis KB, Wang X, Kim M-J, DelBello MP, Strakowski SM, Adler CM:  Elevated lactate levels and impaired neural circuit in manic bipolar disorder I.  Presented at the 17th Annual Meeting of International Society of Magnetic Resonance in Medicine, Honolulu, Hawaii, 2009.
  12. Shear PK, Dawson EL, DelBello MP, Adler CM, Fleck DE, McElroy S, Strakowski, SM:  Nature and frequency of impulsive behaviors in healthy young adults.  Presented at the American Psychological Association,  Honolulu, Hawaii, 2009
  13. McNamara RK, Able J, DelBello MP, Weber WA, Jarvis KB, Strakowski SM, Adler CM:  Chronic docosahexaenoic acid treatment dose-dependently increase erythrocyte docosahexaenoic acid composition and augments frontal cortex activation during performance of a sustained attention task in healthy boys.  Presented at the Society of Biological Psychiatry 64th Annual Meeting, Vancouver, Canada, 2009
  14. Long E, Shear PK, DelBello MP: Facial affect labeling and social judgments in adolescents with bipolar disorder in mixed or depressed mood sates.  Presented at the International Neuropsychological Society Meeting, Atlanta, Georgia, 2009.
  15. Shear PK, Dawson E, DelBello MP, Adler CM, Fleck D, McElroy S, Strakowski SM.  Nature and frequency of impulsive behaviors in healthy young adults.  Presented at the American Psychological Association Meeting, Toronto, Canada, 2009.

                                              

                                               2010

  1. DelBello, MP, Adler CM, Eliassen J, Mills N, Strakowski SM: Neurofunctional brain abnormalities in adolescents at-risk for bipolar disorder.  Biol Psychiatry Suppl 67:9, 2010.
  2. McNamara RK, Strimpfel J, Jandacek R, Rider T, Tso P, Nandagopal J, DelBello MP.  Adolescents with major depressive disorder exhibit selective deficits in erythrocyte docosahexaenoic acid composition: Dissociation from antidepressant medication effects.  Biol Psychiatry Supple 67:9, 2010.
  3. Shah A, Fleck D, DelBello MP, Mills NP. Structural volumes of the cerebellar vermis in a pediatric bipolar population with comorbid ADHD. American Psychiatric Association Annual Meeting, New Orleans, LA, NR 2-7, 2010
  4. Adler CM, DelBello MP, Weber WA, Jarvis KB, Welge JA, Chu W-J, Strakowski SM:  Prefrontal N-acetylaspartate concentrations in manic bipolar patients associated with treatment response to quetiapine.  Presented at the Annual Meeting of the Society of Biological Psychiatry, New Orleans, Louisiana, 2010.
  5. Strawn JR, Adler CM, Eliassen  JC, Chu W-J, Cerullo MA, Whitsel RM, Weber WA, Strakowski SM, DelBello MP:  Neurophysiology and neurochemistry of generalized anxiety disorder in adolescents.  Presented at the American Academy of Child and Adolescent Psychiatry, Scientific Proceeding 57th Annual Meeting, New York, New York, 2010.
  6. Chu W-J, Norris MM, Kotwal R, Adler CM, Kim M-J, Whitsel R, Lee J-H, DelBello MP, Strakowski SM:  Clinical 1H MRS studies of glutamatergic neurotransmission in bipolar disorder.  Presented at the Annual Meeting of International Society of Magnetic Resonance in Medicine, Stockholm, Sweden, 2010.
  7. Lee J-H, Dudley J, Wade WA, Chu W-J, Norris M, DelBello MP, Adler CM, Strakowski SM:  Decreased pHi and [ADP] in anterior cingulated cortex of bipolar disorder: further evidence of mitochondrial dysfunction.  Presented at the Annual Meeting of International Society of Magnetic Resonance in Medicine, Stockholm, Sweden, 2010.
  8. Lamy M, Eliassen JC, Allendorfer JB, Cerullo MA, Madore M, Lee J-H, DelBello MP, Adler CM, Strakowski SM:  Test-retest reliability of an integrated attentional-emotional task.  Presented at the Organization for Human Brian Mapping, Barcelona, Spain, 2010.
  9. McNamara RK, Able J, Jandacek R, Rider T, Tso P, Eliassen J, Alfieri D, Weber WA, Jarvis KB, DelBello MP, Strakowski SM, Adler CM:  Modulation of functional activity in the prefrontal cortex of healthy children by docosahexaenoic acid supplementation: a placebo-controlled dose ranging fMRI study.  A Celebration of DHA, Royal Society of Medicine, London, England, 2010.
  10. Adler CM, DelBello MP, Weber WA, Jarvis KB, Welge JA, Chu W-J, Strakowski SM:  Prefrontal N-acetylaspartate concentrations in manic bipolar patients associated with treatment response to quetiapine.  American College of Neuropsychopharmacology Annual Meeting, Miami, Florida, 2010
  11. McNamara RK, DelBello MP, Janacek R, Rider T, Tso P, Straus A, Lipton J:  Antipsychotic medications regulate fatty acid biosynthesis in rats: implications for hypertriglyceridemia and metabolic dysregulation.  American College of Neuropsychopharmacology Annual Meeting, Miami, Florida, 49: S228, 2010
  12. Madore MR, Fleck DE, DelBello MP, Mills NP, Adler CM, Shear PK, Strakowski SM:  Cerebellar decrements in adolescents with bipolar disorder.  Society for Neuroscience, San Diego, California, 2010.
  13. Strawn JR, Adler CM, Eliassen JC, Chu W-J, Whitsel RM, Weber WA, Strakowski SM, DelBello MP:  Neurophysiology and Neurochemistry of generalized anxiety disorder in adolescents.  American Academy of Child and Adolescent Psychiatry 57th Annual Meeting, New York, New York, 2010.
  14. DelBello MP:  Now and later of mood stabilizers and antipsychotics in youth. American Academy of Child and Adolescent Psychiatry 57th Annual Meeting, New York, New York, 2010.
  15. DelBello MP:  Evidence-based pharmacological interventions for children and adolescents with and at risk for developing bipolar disorder.  American Academy of Child and Adolescent Psychiatry 57th Annual Meeting, New York, New York, 2010.
  16. Chang KD, Foster VJ, Horrigan JP, Dudley TK, DelBello MP:   Tolerability of adjunctive lamotrigine in youth with bipolar I disorder: Preliminary findings from the open-label phase.  American Academy of Child and Adolescent Psychiatry 57th Annual Meeting, New York, New York, 2010.
  17. Strawn JR, DelBello MP:  Neurophysiology and neurochemistry of generalized anxiety disorder in adolescents.  American Academy of Child and Adolescent Psychiatry 57th Annual Meeting, New York, New York, 2010.
  18. DelBello MP, Adler CM, Mills NP, Eliassen JC, Strakowski SM:  Anterior limbic abnormalities and pharmacological treatment effects in adolescents with a bipolar parent.  Presented at the American Academy of Child and Adolescent Psychiatry, 57th Annual Meeting New York, New York, 2010.

                                               2011

  1. Long EA, Shear PK, Adler CM, Strakowski SM, Anthenelli RM, Albertz A, Beavers J, Jarvis LE, DelBello MP:  Fluency abilities in adolescents with co-occurring bipolar and alcohol use
  2. Burciaga J, Shear PK, Weber WA, DelBello MP:  Marijuana craving and memory in bipolar disorder.  International Neuropsychological Society 39th Annual Meeting, Boston, Massachusetts, 2011.
  3. Madore MR, Allendorfer J, Lamy M, Fleck DE, Cerullo M, Eliassen J, Shear PK, Adler CM, DelBello MP, Strakowski SM:  Functional role of the cerebellar vermis in emotional processing.  International Neuropsychological Society 39th Annual Meeting, Boston, Massachusetts, 2011.
  4. Black JJ, Hefner JL, Anthenelli RM, Beavers JN, Adler CM, Strakowski SM, DelBello MP.  Predictors of nicotine telescoping in adolescents with bipolar disorder and co-occurring substance use disorder: A pilot study.   Annual Meeting of the Society for Research on Nicotine and Tobacco, Toronto, Ontario, February 2011.
  5. McNamara RK, Adler CM, Strimpfel JM, Strawn JR, Jandacek R, Tso P, Mills NP, Rider T, Strakowski SM, DelBello MP.  Adolescents at high-risk or ultra high-risk for developing bipolar I disorder exhibit erythrocyte long-chain omega-3 fatty acid deficits compared with low-risk healthy controls.  Society of Biological Psychiatry, 67:S., 2011.
  6. McNamara RK, Adler CM, Strawn JR, Strimpfel JM, Mills NP, Wulsin L, Jandacek R, Rider T, Tso P, Strakowski SM, DelBello MP
  7. Adolescent bipolar I disorder patients exhibit erythrocyte long-chain omega-3 fatty acid deficits during acute mania and euthymia following pharmacotherapy:  Support for a trait versus state feature.  Society of Biological Psychiatry, 67: S, 2011.
  8. McNamara RK, Adler CM, Strawn JR, Strimpfel JM, Weber W, Chu W-J, Jandacek R, Rider T, Tso P, Strakowski SM, DelBello MP.  Adolescents with major depressive disorder exhibit reversible erythrocyte docosahexaenoic acid deficits:  Association with depression symptom severity and cortical 1H MRI metabolite concentrationsSociety of Biological Psychiatry 67: S, 2011.
  9. Danielyan A, Welge JA, Shear PK, Adler CM, Chang K, DelBello MP.  Executive functioning of adolescents with depression associated with bipolar disorder.  Presented at the Annual Meeting of the NIMH-NCDEU, Boca Raton, Florida, June, 2011.
  10. Strawn JR, Bitter SM, Cerullo MA, Whitsel R, Weber WA, Eliassen JC, Adler CM, Strakowski, SM, DelBello MP.  Neurocircuitry of generalized anxiety disorder in adolescents: A functional connectivity study.  Presented at the American and Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto, Ontario, October 2011. 
  11. DelBello MP, Hochadel TJ, Portland KB, Mehra S, Khan A, Katic A, Emslie GJ.   A double-blind, placebo-controlled study of Selegiline Transdermal System (STS) in depressed adolescents.  Presented at the American and Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto, Ontario, October 2011. 
  12. DelBello MP, Welge JA, Adler CM, Beavers JN, Strakowski SM, Anthenelli R.  Topiramate for adolescents with co-occurring cannabis use and bipolar disorders.  Presented at the American and Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto, Ontario, October 2011. 
  13. Patino LR, Adler CM, Mills NP, Strakowski, SM, Fleck D, Welge JA, DelBello, MP.  Decreased conflict driven adaptation in individuals at familial risk for developing bipolar disorder.  Presented at the American and Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto, Ontario, October 2011. 
  14. Danielyan A, Welge JA, Zheng S, Adler CM, Chang OD, DelBello MP.  Characteristics of the child behavioral checklist in adolescents with depression associated with bipolar disorder.  Presented at the American and Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto, Ontario, October 2011. 
  15. Reid-Schneider M, Weber WA, Patino LR, Mills NP, Adler CM, DelBello MP.  Conflict monitoring and conflict-driven adaptation in adolescents with bipolar disorder.  Presented at the American and Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto, Ontario, October 2011. 
  16. Adler CM, Kraft EM, Jarvis KB, Weber WA, Strakowski SM, DelBello MP.  Structural and functional correlates to the development of comorbid substance use disorders in adolescents with bipolar disorder.  Presented at the American and Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto, Ontario, October 2011. 
  17. DelBello MP.  Neurofunctional effects of ziprasidone in adolescent bipolar disorder.  Presented at the American and Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto, Ontario, October 2011. 
  18. DelBello MP, Hochadel TJ, Portland KB, Katic A, Khan A, Emslie G.  A double-blind, placebo-controlled study of selegiline transdermal system (STS) in depressed adolescents.   American College of Neuropsychopharmacology 50th Annual Meeting, Waikoloa, Hawaii, December 2011.
  19. DelBello MP.  Anterior limbic abnormalities in youth with bipolar parent.  American College of Neuropsychopharmacology 50th Annual Meeting, Waikoloa, Hawaii, December 2011.
  20. Fleck DE, Smith MS, Durling MJ, Geracioti TD, Ekhator NN, Nelson EB, DelBello MP, Adler CM, Strakowski SM.  Lack of stress reactivity to an extended continuous performance task in symptomatic outpatients with bipolar disorder.  A pilot study.  American College of Neuropsychopharmacology 50th Annual Meeting, Waikoloa, Hawaii, December 2011.
  21. Adler CM, Thompson TL, DelBello MP, Blom TJ, Fleck DE, Strakowski, SM.  The relationship between serum lithium concentrations and clinical response in bipolar depression.  American College of Neuropsychopharmacology 50th Annual Meeting, Waikoloa, Hawaii, December 2011.
  22. Cerullo M, Eliassen J, Fleck DE, Weber WA, Adler CM, DelBello MP, Strakowski SM.  Major depressive disorder and bipolar disorder subjects exhibit different functional brain activation during a depressive episode.  American College of Neuropsychopharmacology 50th Annual Meeting, Waikoloa, Hawaii, December 2011.

                                               2012

  1. Long  EA,  Shear PK, Mills NP, Adler CM, Strakowski SM, DelBello MP.  Relationship between family environment and emotional processing in adolescents at risk for bipolar disorder with bipolar disorder.  Accepted for Presentation at 40th Annual Meeting of the International Neuropsychological Society, Montreal, Canada, February 2012.
  2. Heffner  JL, Blom TJ, Anthenelli RM, Adler CM, Beavers JN, Strakowski SM, DelBello MP. Gender differences in the effects of topiramate on cigarette smoking in adolescents with bipolar disorder and cannabis use disorders.  Accepted for presentation at 2012 SPNT Annual Meeting, Houston, Texas, 2011.
  3. Brickey MN, Heffner JL, Adler CM, Strakowski SM, Anthenelli RM, Beavers JN, DelBello MP.  Prevalence and correlates of nicotine dependence in adolescents with bipolar disorder and cannabis use disorders.  Accepted for presentation at 2012 SPNT Annual Meeting, Houston, Texas, 2011.
  4. Dawson EL, Shear PK, Strakowski SM, Fleck DE, Adler CM, DelBello MP.  Impulsivity as a predictor of psychosocial functioning in adults with bipolar disorder recently hospitalized for acute mania.  Accepted for presentation at the Annual Meeting of the International Neuropsychological Society Conference, Montreal, Canada, 2012.
  5. Chu W-J, Eliassen JC, Lee J-H, Adler CM, DelBello MP, Fleck DE, Komoroski RA, Norris MM, Strakowski SM.  Correlation between fMRI activation and glutamate levels in healthy and bipolar subjects.  Presented at the Society of Biological Psychiatry meeting in Philadelphia, May 2012.
  6. McNamara RK,Janacek R, Rider T, Tso P, Strakowski SM, DelBello MP.  First-episode adolescent bipolar disorder patients exhibit elevated indices of delta-6 desaturase activity during acute mania and euthymia following pharmacotherapy.  Biol Psychiatiry, 71:8S, 105S, 2012. 
  7. McNamara RK, Adler CM, Strawn J, Weber W, Strimpfel J, Jandacek R, Rider T, Tso P, Strakowski SM, DelBello MP.  Adolescents with major depressive disorder exhibit reversible erythrocyte long-chain omega-3 fatty acid deficits: association with mood symptoms and functional cortical activity.  Biol Psychiatry, 71:8S, 106S, 2012
  8. Burciaga J, Shear PK, Weber WA, DelBello MP, Eliassen J, Adler CM.  Patterns of brain activation in response to a marijuana-specific cue reactivity task in bipolar and healthy adolescents.  Poster accepted for presentation at the International Neuropsychological Society Meeting, Montreal, Canada, 2012.
  9. Schneider M, Bitter S, Mills NP, Weber WA, Eliassen J, Lamy M, Adler CM, Strakowski SM, DelBello MP.  Longitudinal changes in amygdale volume and activation following the first episode of bipolar disorder.  Presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  10. DelBello MP.  Treatment of comorbid and high-risk conditions in youth with and at risk for developing bipolar disorder.  Presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  11. DelBello MP, Bitter S, Mills NP, Strawn JR, Strakowski SM, Adler CM.  Risk of antidepressant induced manic symptoms in child and adolescent offspring of bipolar parents.  Presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  12. DelBello MP.  Evidence-based pharmacological interventions for children and adolescents with bipolar disorder and commonly comorbid psychiatric disorders.  Presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  13. DelBello MP.   Treatment of comorbid and high-risk conditions in youth with and at risk for developing bipolar disorder.  Presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  14. Keeshin BR, Strawn JR, Granger DA, DelBello MP, Putnam Jr., F.  Neuroendocrine function in recently sexually abused adolescent girls with an without posttraumatic stress disorder.  Poster presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  15. Danielyan A, Blom TJ, Welge JA, Chang KD, Howe M, Adler CM, DelBello MP.  Cognitive, family and quality of life characteristics of youth in depressive phase of bipolar disorder.   Poster presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  16. Schneider M, Weber WA, Strawn JR, Welge JA, Adler CM, Strakowski SM, DelBello MP.  Altered functional activation during a task of sustained attention in bipolar adolescents during their first hospitalization for mania.   Poster presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  17. Danielyan A, Weber WA, Blom TJ, Eliassen J, Adler CM, Strawn JR, DelBello MP.  Quality of life in adolescents with bipolar disorder with comorbid ADHD: Role of impaired facial emotion processing and social cognition.  Poster presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  18. DelBello MP, Change KD, Robb A, Foster VJ, Hammer AE, Wamil, AW.  Feasibility of a maintenance study in bipolar youth: Preliminary characterization of subjects who stabilized on adjunctive lamotrigine.  Poster presented at the 59th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Francisco, California, October 2012.
  19. DelBello MP.  Neurofunctional effects of ziprasidone in manic adolescents with bipolar disorder.  Presented at the 51st Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, December 2012. 
  20. Reid-Schneider M, Weber WA, Welge J, Adler CM, Strakowski SM, DelBello MP.  First hospitalization manic youth show functional alterations during a task of sustained attention.  Presented at the 51st Annual Meeting of the American College of Neuropsychopharmacology Hollywood, Florida, December 2012. 
  21. DelBello MP, Holland CD, Landry J, Usher R, Schoer R, Dingankar M.  Safety and efficacy of olanzapine/fluoxetine combination versus placebo in patients aged 10 to 17 in the acute treatment of major depressive episodes associated with bipolar disorder.  Presented at the 51st Annual Meeting American College of Neuropsychopharmacology, Hollywood, Florida, December 2012. 
  22. Fleck DE, Chu W-J, Komoraski R, Eliassen J, Lee JH, Norris M, Cerullo M, Adler CM, DelBello MP, Strakowski SM.   Longitudinal assessment of neurochemical changes in first-episode mania following lithium treatment: An interim MRS analysis from the bipolar disorder imaging and treatment research center.  Presented at the 51st Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, December 2012. 
  23. Strawn J, Wehry AM, Cerullo M, Eliassen J, Strakowski SM, Adler CM, DelBello MP.  Gray matter volumes in pediatric generalized anxiety disorder: A voxel-based morphometry study.  Presented at the 51st Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, December, 2012. 
  24. Cerullo M, Lamy M, Smith C, Milburn B, Fleck DE, Eliassen J, Strawn J, Adler CM, DelBello MP, Strakowski SM.  Functional activation differences during an impulsivity task occur in subjects with bipolar disorder compared to major depressive disorder during a depressive episode.  Presented at the 51st Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, December 2012. 
  25. Patino Duran LR, Adler CM, Mills NP, Strakowski SM, Fleck DE, Welge J, DelBello MP.  Conflict monitoring and adaptation in individuals at familial risk for developing bipolar disorder.   Presented at the 51st Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, December 2012. 

                                               2013

  1. Chu W-J, Norris M, Northern T, Storrs J, Fleck DE, Fugate E, Lee JH, Adler CM, DelBello MP, Nasrallah HA, Strakowski SM.  Correlations among fMRI, MRS and working memory in healthy, bipolar and schizophrenic subjects.  Presented at the 21st Annual Meeting of the International Society for Magnetic Resonance in Medicine in Salt Lake City, Utah, April 2013.
  2. Chu W-J, Norris M, Northern T, Storrs J, Fleck DE, Fugate E, Lee JH, Adler CM, DelBello MP, Nasrallah HA, Strakowski SM. Relationships between metabolite concentrations and working memory performance in patients with bipolar disorder and schizophrenia.  Presented at the 21st Annual Meeting of the International Society for Magnetic Resonance in Medicine in Salt Lake City, Utah, April 2013.
  3. DelBello MP, Ader CM, Strawn JR, Strakowski SM.  Antidepressant induced mania in adolescents at-risk for bipolar disorder.  Presented at the 68th Annual Scientific Meeting of the Society of Biological Psychiatry in San Francisco, California, May 2013.
  4. Cerullo M, Welge J, Strawn JR, Eliassen JC, Fleck D, Rummelhoff E, Weber WA, Strakowski SM.  Neurochemical and neurophysiological effects of lithium across mood state.  Poster presented at the 68th Annual Scientific Meeting of the Society of Biological Psychiatry in San Francisco, California, May 2013.
  5. DelBello MP, Saliba LJ, Strawn JR, Barzman, DH, Eliassen J, Patino, LR, Weber WA, Welge JA, Adler CM, Strakowski SM, McNamara RM.  Functional prefrontal differences in youth with and at-risk for developing mania.  Presented at the 60th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in Orlando, Florida, October 2013.
  6. DelBello, MP, Strawn JR, Patino LR, Stahl L, Weber WA, Welge JA, Adler CM, Strakowski SM, McNamara RM.  A double-blind placebo controlled study of omega-3 fatty acid supplementation for depressed bipolar offspring.  Presented at the 60th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in Orlando, Florida, October 2013.
  7. Schneider, MR, Patino LR, Bitter S, Weber WA, Eliassen JC, Lamy M, Adler CM, Strakowski, SM, DelBello MP.  Functional activation patterns associated with mania and euthymia in adolescents early in the course of bipolar disorder.   Poster presented at the 60th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in Orlando, Florida, October 2013.
  8. Danielyan A, Weber WA, Blom TJ, Klein C, Eliassen J, Adler CM, Strawn JR, DelBello MP.  Quality of life in adolescents with bipolar disorder with comorbid ADHD: Role of impaired facial emotion processing and social cognition.  Poster presented at the 60th Annual Meeting of the American Academy of Child & Adolescent Psychiatry in Orlando, Florida, October 2013.
  9. Schneider MR, Benanzer T, Weber WA, Patino LR, Strawn JR, Welge J, Adler CM, Strakowski SM, DelBello MP.  Neurochemistry of first-hospitalization manic youth.  Abstract presented at the 52nd Annual Conference of the American College of Neuropsychopharmacology in Hollywood, Florida, December 2013.
  10. Adler, CM, Davis A, DelBello MP, Weber WA, Eliassen JC, Blom T, Welge J, Fleck D, Strakowski SM.  Longitudinal fMRI study of quetiapine in bipolar mania.  Abstract presented at the 52nd Annual Conference of the American College of Neuropsychopharmacology in Hollywood, Florida, December 2013.
  11. DelBello MP, Welge J, Strawn J, Patino LR, Stahl L, Blom T, Strakowski SM, McNamara R.  A double-blind placebo-controlled study of long-chain omega-3 fatty acid supplementation for depression in youth at ultra-high risk for bipolar disorder.  Poster presented at the 52nd Annual Conference of the American College of Neuropsychopharmacology in Hollywood, Florida, December 2013.

                                               2014

  1. Wegman CJ, Schwartz MS, Wehry AM, Eliassen JC, Patino LR, Adler CM, Strakowski SM, DelBello MP, Strawn JR.  Cortical morphology in children & adolescents with generalized anxiety disorder.  Department of Psychiatry & Behavioral Neuroscience & Center for Imaging Research, University of Cincinnati, Cincinnati, Ohio, 2014.
  2. Strawn JR, Wehry AM, Cerullo MA, Eliassen JC, Weber WA, Chu, W-J, Whitsel RM, Strakowski SM, Adler CM, DelBello MP.   Gray matter volumes in pediatric generalized anxiety disorder: a voxel-based morphometry study.  Department of Psychiatry & Behavioral Neuroscience & Center for Imaging Research, University of Cincinnati, Cincinnati, Ohio, 2014.
  3. Wehry AM, McNamara RK, Adler CM, Eliassen JC, Croarkin PE, Cerullo MA, Strakowski SM, DelBello MP, Strawn JR.  Distinct neuroanatomy of anxiety and depression in children and adolescents: a voxel-based morphometry study.   Department of Psychiatry & Behavioral Neuroscience & Center for Imaging Research, University of Cincinnati, Cincinnati, Ohio, 2014.
  4. Cotton S, Luberto CM, Sears RW, Strawn J, Wasson R, Blom T, Stahl L, DelBello MP.  Mindfulness-based cognitive therapy for youth with anxiety disorders at risk for bipolar disorder: A pilot trial.  Poster presented at the Annual Meeting of the International Research Congress on Integrative Medicine and Health, Miami, Florida, May 2014.
  5. McNamara RK, Strawn JR, Stahl L, Jandacek R, Tso P, Rider T, DelBello MP.  Long-chain omega-3 fatty acid deficits in youth with or at high or ultra-high risk for bipolar disorder are not due to impaired peroxisomal function.  Poster presented at the 69th Annual Meeting of the Society of Biological Psychiatry, Mary, 2014.
  6. Welge JA, Strakowski SM, Eliassen JC, Lamy M, Allendorfer JB, Adler CM, DelBello MP, Fleck DE.  Factor analysis of regional brain activation in bipolar and health individuals reveals a consistent modular structure.  Post presented at the 69th Annual Meeting of the Society of Biological Psychiatry, May, 2014.
  7. McNamara RK, Strawn JR, Stahl L, Weber W, Welge J, Patino R, Strakowski SM, DelBello MP.  Effects of long-chain omega-3 fatty acid monotherapy on cortical biochemistry in depressed bipolar offspring: A double-blind placebo-controlled 1H MRS study.  Poster presented at the 69th Annual Meeting of the Society of Biological Psychiatry, May, 2014.
  8. DelBello MP.  Evidence-based pharmacological interventions for mania, depression, and maintenance in children and adolescents with bipolar disorder.  Abstract presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  9. Findling RL, Chang K, Foster V, Krishen A, DelBello MP.  Double-blind, placebo-controlled, 36-week maintenance study of lamotrigine in youth with bipolar I disorder.  Poster presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  10. Detke HC, DelBello MP, Landry J, Dittmann RW.  A 52-233k, open-label study of oral olanzapine with a randomized behavioral weight intervention in adolescents with schizophrenia or bipol
  11. ar I disorder.  Poster presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  12. Robb AS, McNamara N, Pavuluri MN, Kafantaris V, Scheffer R, Frazier JA, Rynn MA, DelBello MP,  Kowatch RA, Rowles B, Lingler J, Martz K, Clemons T, Taylor-Zapata P, Findling RL.  Lithium in the acute treatment of a manic or mixed episode in pediatric bipolar I disorder: A randomized, double-blind, placebo-controlled study.   Poster presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  13. DelBello MP, McNamara RM, Strawn JR, Patino LR, Stahl L, Weber WA, Welge JA, Strakowski SM.  Effects of long-chain omega-3 fatty acid supplementation on cortical integrity in adolescents at high risk of developing mania.  Presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  14. Wehry AM, McNamara RM, Heyse H, Eliassen JC, Croarkin PE, Adler, CM, Strakowski SM, DelBello MP.  The neuroanatomy of anxious-depression in adolescents: A voxel-based morphometry study.   Poster presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  15. Strawn JR, Cotton S, Luberto CM, Patino LR, Stahl L, Weber WA, Eliassen JC, Sears RW, DelBello MP.  Neurofunctional changes associated with mindfulness-based cognitive therapy in anxious youth at risk of developing bipolar disorder.  Poster presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  16. Strawn JR, Wegman CJ, Heyse H, Weber WA, Patino LR, Eliassen JC, DelBello MP.  The neurofunctional impact of anxiety on attention processing in adolescents with ADHD.  Poster presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  17. Patino LR, DelBello MP, Saliba LJ, Strawn JR, Barzman DH, Eliassen JC, Weber WA, Welge JA, Adler CM, McNamara RM, Strakowski SM.  Presented at the 61st Annual Meeting of the American Academy of Child & Adolescent Psychiatry in San Diego, California, October 2014.
  18. DelBello MP.  Functional prefrontal differences in youth with and at risk for developing mania.   Presented at 53rd Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona, December 2014.  (Panel Session)
  19. McNamara R, Strawn J, Stahl L, Weber W, Welge J, Patino R, Strakowski S, DelBello MP.  Effects of fish oil monotherapy on emotion-generated cortical activity in depressed bipolar offspring: A double-blind placebo-controlled fMRI study.  Poster presented at 53rd Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona, December 2014.
  20. Schneider MR, Patino LR, Weber W, Eliassen J, Adler CM, Strakowski S, DelBello MP.  Neural correlates and developmental progression of executive function in youth with bipolar disorder.   Poster presented at 53rd Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona, December 2014.
  21. Nery F, Weber W, Eliassen J, Norris M, Robles T, Wilson A, Durling M, Strakowski S, Adler CM, DelBello MP.   Changes in cortical thickness in you offspring of parents with bipolar disorder type I before and after developing their first mood episode.  .   Poster presented at 53rd Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona, December 2014.

Research Grants as Principal Investigator:

Project:            Phenomenological, neurocognitive, and neuroimaging characterization of children at high risk for developing bipolar disorder.

Funding:          Theodore and Vada Stanley Foundation Research Award, 1998-2000.

Project:            Quetiapine in the treatment of children and adolescents with mania associated with bipolar disorder.

Funding:          AstraZeneca Pharmaceuticals, 2000-2001.

Project:            Magnetic resonance spectroscopy and olanzapine in bipolar adolescents at first hospitalization.

Funding:          Eli Lilly Inc, 2001-2003.

Project:            The Neurochemistry and treatment of adolescent bipolar depression.

Funding:          Klingenstein Third Generation Foundation, 2001-2003.

Project:            Cerebellar abnormalities in adolescent bipolar disorder

Funding:          NARSAD Young Investigator Award, 2001-2003.

Project:            Topiramate in adolescents with bipolar disorder

Funding:          Johnson and Johnson, Inc., 2001.

Project:            Neuroanatomic abnormalities in adolescents with bipolar disorder

Funding:          National Institute of Mental Health  

K23  MH63373  01/01/02-12/31/06 

Project:            Depakote loading for the treatment of aggression associated with mania in hospitalized bipolar adolescents.

Funding:          Abbott Laboratories, 2002

 

Project:            A double blind randomized trial of quetiapine vs. divalproex for the treatment of hospitalized adolescents with mania associated with bipolar disorder.

Funding:         AstraZeneca Pharmaceuticals 2002-2004

Project:           Topiramate in inpatient bipolar adolescents hospitalized for a manic episode

Funding:         Johnson and Johnson, Inc., 2002

Project:            A single-blind prospective study of quetiapine for the treatment of mood disorders in adolescents who are at high risk for developing bipolar disorder.

Funding:         AstraZeneca Pharmaceuticals 2002-2004

Project:            Differentiating the neurocircuitry of bipolar and attention deficit hyperactivity disorders in adolescents.

Funding:         NARSAD Young Investigators Award 08/01/04-06/01/06

Project:           Neurobiology of pediatric bipolar disorder.

Funding:         Heinz C. Prechter Foundation 2004-2006

Project:            A double-blind randomized placebo-controlled study of quetiapine for the treatment of depression in adolescents with bipolar disorder.

Funding:         AstraZeneca Pharmaceuticals, 2006-2008

Project:           Multimodal neuroimaging in adolescent bipolar disorder.

Funding:         Dean’s Bridge Award, University of Cincinnati College of Medicine, 2008

        

Project:            Neurochemical effects of quetiapine for the treatment of depression in adolescents with bipolar disorder.

Funding:         AstraZeneca Pharmaceuticals, 2006-2008

Project:            Identifying biomarkers of abnormal metabolism in adolescents with bipolar disorder using proton and phosphorous magnetic resonance imaging

Funding:         NARSAD Independent Investigator Award, 2006-2009

Project:            The neurochemical and neurofunctional effects of ziprasidone in pediatric bipolar disorder

Funding:          Pfizer Pharmaceuticals, 2006-2007

Project:            The neuropharmcological effects of Equetro

Funding:          Shire Pharmaceutical, 2006-2008

Project:           Topiramate for co-occurring cannabis use and bipolar disorders in adolescents

Funding:          National Institute of Drug Abuse, R01 DA022221 9/26/06-6/30/09

Effort:             5%

Project:            Inositol abnormalities in adolescent bipolar disorder

Funding:          Thrasher Research Fund 2005-2008

Project:            A double-blind placebo controlled study of topiramate for the prevention of weight gain in children and adolescents with bipolar disorder treated with olanzapine

Funding:          Eli Lilly Pharmaceuticals, 2006-2009

Effort:             As needed

Project:            Topiramate for alcohol use in bipolar adolescents

Funding:          National Institute of Alcohol Abuse and Alcoholism, R21 AA016372, 4/15/08-3/31/10

Effort:             10%

Project             The neurochemical and neurofunctional effects of ziprasidone in pediatric bipolar

Funding:          Pfizer Pharmaceuticals

Effort:             As needed

Project:            Topiramate for co-occurring cannabis use and bipolar disorders in adolescents.

Funding:          National Institute on Drug Abuse, R01 DA022221, 09/26/06-6/30/010

Effort:             5%

Project:            Neuroimaging predictors of treatment response

Funding           National Institute on Drug Abuse, Supplement to R01 DA22221, 09/26/06-6/30/10

Effort:             As needed

Project:            Project 3: Neurobiological characterization of offspring of bipolar parents, of the University of Cincinnati Bipolar Disorder Imaging & Treatment Research Center (BITREC)

Funding:          National Institute of Mental Health P50 MH077138-01 (PI-Strakowski) 07/01/07-

06/30/12

Effort:             15%

Project:            Neurochemical effects of omega-3 fatty acids in adolescents at risk for mania

Funding:          National Institute of Mental Health, R34 MH083924, 06/15/09-03/31/12

Effort:             12%

Project:            Multimodal neuroimaging of treatment effects in adolescent mania

Funding           National Institute of Mental Health, R01 MH080973, 8/01/09-03/01/15

Effort:             30%

 

Project:            A double-blind placebo-controlled study of exenatide for the treatment of weight gain associated with olanzapine in obese adults with bipolar disorder.

Funding:          Eli Lilly and Company and Amylin, University of Cincinnati, 2008-

Effort:             As needed

Project:           Neural basis of mindfulness in mood dysregulated youth.

Funding:          University of Cincinnati Neuroscience Institute

Effort:             As needed

Project:            Mindfulness-based cognitive therapy for the treatment of anxiety in youth with a familial risk for bipolar disorder.

Funding:         Depression and Bipolar Alternative Treatment Alliance

Effort:             As needed

Project:            MOBILITY: Improving Patient-Centered Outcomes Among Overweight and Obese Youth with Bipolar Disorders Treated with Second-Generation Antipsychotics

                        Funding:          Patient-Centered Outcomes Research Institute (PCORI), 9/1/15-8/31/20

                        Effort:             30%

Project:            Neurofunctional Predictors of Treatment Response in Adolescents with Generalized Anxiety Disorder (GAD), (PI-Strawn)

                        Funding:         NIMH, K23MH106037, 9/23/14-8/30/18

Effort:             Primary mentor

Project:            Neuroimaging of Risk Factors for Adolescent Bipolar Disorder

Funding:         NIMH, R01MH097818, 7/8/15-6/30/20

Effort:             20%

   
   

Research Grants as Co-investigator:

Project:            A double-blinded placebo controlled study of the pharmacotherapy of adolescent body dysmorphic disorder (PI-Brian McConville, MD)

Funding:          NIMH, 1999-2002

Project:            A multi-site collaborative study of the treatment of childhood and adolescent bipolar disorder (PI-Robert Kowatch, MD)

Funding:         NIMH, R01 MH060710, 11/01/99-08/31/05

Project:            The University of Cincinnati Stanley Research Foundation Center for the Neuroimaging Study of Bipolar Disorder (PI-Stephen Strakowski, MD)

Funding:          Theodore and Vada Stanley Medical Research Institute, 2001-2006

Project:            Neurocognition in children at risk for bipolar disorder (PI-Paula Shear, PhD)

Funding:         NIMH   R03 MH63964-01, 12/01/02-10/30/05

Project:            The effectiveness and tolerability of depakote vs. seroquel for reactive aggression and agitation in adolescents with co-occurring bipolar and disruptive behavior disorders. (PI-Drew Barzman, MD)

Funding:          AstraZeneca Pharmaceuticals, 2004-2006

Project:           Impulsivity as a core trait of bipolar disorder (PI-Stephen Strakowski, MD)

Funding:         NIMH R01 MH66626, 03/01/04-12/31/08     

Effort:             2.5%                         

Project:            Executive functioning deficits in youth diagnosed with bipolar disorder and ADHD: Are they additive?  (PI-Juliet Warner, MS)

Funding:          Ohio Department of Mental Health, 2004-2006

Project:            Manic distractibility and frontosubcortical processing (PI-David Fleck, PhD)

Funding:          NIMH K23 MH070849, 2004-2008

Effort:             As needed

Project:            The effectiveness and tolerability of IM ziprasidone for agitation in inpatient children and adolescents. (PI-Drew Barzman, MD)

Funding:          Pfizer, 2005-2007

Project:            Longitudinal Assessment of Manic Symptoms (PI-Robert Kowatch, MD, Role: Subcontract PI)

Funding:         NIMH R01 MH073816, 09/16/05-10/31/07

Project:            Family Focused Treatment for bipolar adolescents (PI- Robert Kowatch, MD, Role: Subcontract PI)               

Funding:          NIMH R01 MH074033, 7/1/06-4/30/11

Effort:             5%

Project:            University of Cincinnati Bipolar Disorder Imaging and Treatment Research Center (BITREC) (PI-Stephen Strakowski, MD; Role: Director, Clinical Assessment and Recruitment Division, Operations and Clinical Assessment Core)

Funding:          National Institute of Mental Health, P50MH077138-01, 7/1/07-6/30/12

Effort:             15%

Project:            Neurofunctional and neurochemical markers of treatment response in bipolar mania (PI-Caleb Adler, MD)

Funding:          National Institute of Mental Health, R01 MH078043

Effort:             5%

Project:            The neurocognitive effects of cannabis use in adolescents with bipolar disorder (PI-Jane Allendorfer, MS)

Funding:          NIDA Minority Supplement

Effort:             As needed

Project:            Visual and auditory perception of emotion in adolescents with bipolar disorder (PI-Mary Foster, MS)

Funding:          Ohio Department of Mental Health, 2005-2009

Effort:             As needed

Project:            Labeling and interpretation of facial affect in depressed adolescents (PI-Elizabeth Long-Gernert, MS)

Funding:          Ohio Department of Mental Health, 2006-2009

Effort:             As needed

Project:            The neurophysiology of fear, attention and disinhibition in adolescents with generalized anxiety disorder. 

Funding:          AACAP Eli Lilly Award (PI- Jeffrey Strawn, MD)

Project:            Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function (PI-Robert McNamara, PhD)

Funding:          Inflammation Research Foundation

Effort:             As needed

Project:            Evaluation of omega-3 fatty acids as a treatment-adjunct in adolescent patients with major depressive disorder exhibiting partial response to SSRI medications: an open-label neuroimaging trial (PI-Robert McNamara, PhD)

Funding:          Inflammation Research Foundation

Effort:             As needed

Funding:          Ohio Department of Health

Project:            Facial Affect Processing Abilities in Adolescents at Risk for Bipolar Disorder (PI-Paula Shear, Ph.D.)

Effort:             As needed

Project:           Risk and Protective Factors for SGA-induced Metabolic Syndrome in Bipolar Youth

Funding:         NIDDK R01 DK097599-01 (McNamara) 07/01/13-06/01/17

Effort:             10%

Pharmaceutical Trials as Principal Investigator:

1.   The efficacy and safety of risperidone in the treatment of adolescents with schizophrenia. Johnson and Johnson Pharmaceutical Research and Development. University of Cincinnati, 2001-2006

2.   The efficacy and safety of risperidone in the treatment of adolescents with schizophrenia: a follow-up trial of RIS-USA-231.  Johnson and Johnson Pharmaceutical Research and Development.  University of Cincinnati, 2001-2006

3.   Double-blind placebo controlled 4-week study of the safety and efficacy of topiramate in children and adolescents with acute manic or mixed episodes of bipolar I disorder. Ortho McNeil Pharmaceuticals.  University of Cincinnati, 2001-2002

4.   Olanzapine versus placebo in the treatment of adolescents with bipolar disorder. Eli Lilly and Company.  University of Cincinnati, 2002-2005

5.   Olanzapine versus placebo in the treatment of adolescents with schizophrenia. Eli Lilly and Company.  University of Cincinnati, 2002-2005

6.   Research on the effectiveness of risperidone in bipolar disorder in adolescents and children (REACH): A double-blind placebo controlled study of the efficacy and safety of risperidone in the treatment of acute mania in bipolar I disorder. Johnson and Johnson Pharmaceutical Research and Development.  University of Cincinnati, 2003-2005

7.   A 27-week open-label trial to characterize the safety and tolerability of orally administered ziprasidone in children and adolescent subjects with bipolar I disorder (manic or mixed), schizophrenia, or schizoaffective disorder.  Pfizer, Inc. University of Cincinnati, 2003-2005

8.    A three-week multi-center randomized double-blind parallel group placebo-controlled phase IIIB study of the efficacy and safety of quetiapine fumarate (seroquel) immediate release tablet in daily doses of 400mg and 600mg compared with placebo in the treatment of children and adolescents with bipolar I mania. AstraZeneca Pharmaceuticals. University of Cincinnati, 2004-2006.

9.    Population pharmacokinetic study in adolescent patients with schizophrenia or bipolar I disorder treated with olanzapine. Eli Lilly and Company. University of Cincinnati, 2005-2006

10.  A 6-week, international, multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase IIIb study of the efficacy and safety of quetiapine fumarate (SEROQUEL) immediate-release tablets in daily doses of 400mg and 800mg compared with placebo in the treatment of adolescents with schizophrenia. AstraZeneca Pharmaceuticals. University of Cincinnati, 2004-2007

11.  An open-label study to evaluate the safety of Depakote ER in the treatment of mania associated with bipolar I disorder in children and adolescents. Abbott, University of Cincinnati, 2004-2006

12.  Four week, double-blind, placebo controlled phase III trial evaluating the efficacy, safety, and pharmacokinetics of flexible doses of oral ziprasidone in children and adolescents with bipolar I disorders (manic or mixed). Pfizer Pharmaceuticals, University of Cincinnati, 2006-

13.   Six-week, double-blind, placebo controlled phase III trial evaluating the efficacy, safety, and pharmacokinetics of flexible doses of oral ziprasidone in adolescent subjects with schizophrenia. Pfizer Pharmaceuticals, University of Cincinnati, 2006-2007

14.  A phase IV, double-blind, placebo-controlled, randomized, flexible-dose study of the safety and efficacy of EMSAM in adolescents with major depression. Somerset, University of Cincinnati, 2007-2012

15.   A 2-year, open label, single-arm safety study of flexibly dosed paliperidone extended release (1.5-12 mg/day) in the treatment of adolescents (12 to 17 Years of Age) with schizophrenia (R076477-PSZ-3002 Study).  Johnson and Johnson Pharmaceuticals, University of Cincinnati, 2007-2011.

16.  A phase IV, multi-center, open-label, safety and effectiveness study of extended-release carbamezapine in the treatment of mania in children and adolescents aged 10-17 years with acute manic or mixed bipolar I disorder. Shire Pharmaceuticals, University of Cincinnati, 2006-2007.

17.   The evaluation of lamictal as add-on treatment for bipolar I disorder in children and adolescents, 10 to 17 years of age. GlaxoSmithKline, University of Cincinnati, 2008-2014.

18.  A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of

       children and adolescents with major depressive disorder.  Eli Lilly and Company, University of

       Cincinnati, 2009-2011.

19.   Study to assess the safety and efficacy of olanzapine and fluoxetine combination versus

        placebo in patients ages 10 to 17 in the treatment of major depressive episodes associated

       with bipolar I disorder.  Eli Lilly and Company, University of Cincinnati, 2009-2011.

20.   A long-term, open-label, single arm safety study of oral olanzapine in the treatment of adolescents with bipolar disorder (manic or mixed episodes) or schizophrenia. Eli Lilly and Company, University of Cincinnati, 2009-2012.

21.   An 8-week multi-center, double-blind, randomized, parallel-group, placebo-controlled study of  the efficacy and safety of quetiapine fumarate extended-release in children and adolescent subjects with bipolar depression.  AstraZeneca Pharmaceuticals, University of Cincinnati, 2009-2010.

22.   A long-term, multicenter, open-label study to evaluate the safety and tolerability of flexible-dose oral aripiprazole (OPC-14597) as maintenance treatment in adolescent patients with schizophrenia or child and adolescent patients with bipolar I disorder, manic or mixed episode with or without psychotic features.  Otsuka (ATTAIN), University of Cincinnati, 2010-

23.   A 26-week open-label, flexible-dose trial of asenapine extension treatment to P06107 in pediatric acute manic or mixed episode associated with bipolar I disorder.  Merck (P05898), University of Cincinnati, 2011-2014.

24.   Efficacy and safety of 3-week fixed-dose asenapine treatment in pediatric acute manic or mixed episodes associated with bipolar I disorder.  Merck (P0607), University of Cincinnati, 2011-2014.    

25.  A multicenter, open-label, sequential-cohort, dose-escalation, 14-day study to explore the tolerability and pharmacokinetics of iloperidone (Fanapt®) 12 to 24 mg/day followed by 26 weeks of flexible dosing (6 to 24 mg/day) in adolescent patients (aged 12 to 17 years) has been amended. Novartis, University of Cincinnati, 2012-

26.  An open-label study evaluating the pharmacokinetics and tolerability of Lu AA21004

      in connection with multiple oral dosing of Lu AA21004 in child and adolescent

      patients with DSM-IV diagnosis of depression or anxiety disorder. Lundbeck, University of Cincinnati, 2012-

27. A Phase III, Randomized double-blind, placebo controlled, parallel-arm, multi-center study measuring the efficacy and safety of PRC-063 in adolescent ADHD patients.  Purdue (063-009), University of Cincinnati, 2014-

28. A six-month, open-label, multi-center study of the safety and efficacy of PRC-063 in adults and adolescents with ADHD.  Purdue (063-012), University of Cincinnati, 2014-

29. Sertraline pediatric registry for the evaluation of safety.  A non-interventional, longitudinal, cohort study to evaluate the effects of long-term sertraline treatment in children and adolescents.  Pfizer Sprites-A0501093, University of Cincinnati, 2013-

30. A 6-week randomized, parallel, double-blind, placebo-controlled, fixed-dose, multicenter study to evaluate the efficacy and safety of lurasidone in adolescents subjects with schizophrenia.  Sunovion (D1050301), University of Cincinnati, 2014-

31. A 104-week, flexible-dose, open-label, multicenter, extension study to evaluate the long-term safety and effectiveness of lurasidone in pediatric subjects with schizophrenia and subjects with irritability associated with autistic disorder.

      Sunovion (D1050302), University of Cincinnati, 2014-

32. A randomized, 6-week, double-blind, placebo-controlled, flexible dose, parallel-group study to evaluate the efficacy and safety of lurasidone in children and adolescent subjects with bipolar I depression.  Sunovion (D1050326), University of Cincinnati2014-

33. Neural basis of mindfulness in mood dysregulated youth.  UCNI Emotional Dysregulation, University of Cincinnati, 2014-

 

Pharmaceutical Trials as Co-investigator:

1.    A comparison of risperidone and haloperidol for prevention of relapse in subjects with schizophrenia and schizoaffective disorder.  Janssen Research Foundation. University of Cincinnati, 1997-1998.

2.    A multi-center, randomized, double-blind, parallel group trial comparing the safety and efficacy of risperidone and olanzapine in schizophrenia and schizoaffective disorder. Janssen Research Foundation. University of Cincinnati, 1997-1998.

3.    A multicenter, placebo and active control, double-blind, randomized study of the efficacy, safety and pharmacokinetics of M100, 907 in schizophrenic and schizoaffective patients (3001).  Hoechst Marion Roussel, Inc.  University of Cincinnati, 1998-1999.

4.    A multicenter, open label, long-term follow-up safety study of M100,907 tablets in schizophrenic and schizoaffective patients who participated in protocol M100,907/3001.  Hoechst Marion Roussel, Inc.  University of Cincinnati, 1998-1999.

5.    An open label comparison of the neurocognitive effects of aripiprazole to olanzapine administered orally in patients with stable psychosis.  Otsuka America Pharmaceutical, Inc.  University of Cincinnati, 1999-2000.

6.    The acute and long-term efficacy of olanzapine in first-episode psychotic disorders: a randomized double-blind comparison with haloperidol. Eli Lilly Pharmaceutical, Inc.  University of Cincinnati, 1998-2001.

7.    An open label follow-on study of long term safety of aripiprazole administered orally in patients with psychosis. Otsuka America Pharmaceutical, Inc. University of Cincinnati, 1999-2002.

8.    Double-blind, placebo-controlled study of venlafaxine ER in children and adolescents with generalized anxiety disorder.  Wyeth-Ayerst Research.  University of Cincinnati, 2000-2001.

9.    Open-label long-term safety study of venlafaxine ER in children and adolescent with major depressive disorder.  Wyeth-Ayerst Research. University of Cincinnati, 2000-2001.

10.  A multicenter, double-blind, placebo-controlled trial of nefazodone in depressed adolescents. Bristol-Myers Squibb. University of Cincinnati, 2001-2002.

11.  A double-blind, placebo-controlled, parallel group, flexible-dose study of

       Venlafaxine ER in children and adolescent outpatients with social anxiety disorder. Wyeth Ayerst Research. University of Cincinnati, 2001-2002.

12.  Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of first-episode psychosis: A randomized double-blind 52-week comparison.  AstraZeneca Pharmaceuticals.  University of Cincinnati, 2002-2004.

13.  A multi-center open-label, flexible dose, parallel group evaluation of the cataractogenic potential of quetiapine fumarate (seroquel) and risperidone (risperdal) in the long-term treatment of patients with schizophrenia or schizoaffective disorder.  AstraZeneca Pharmaceuticals. University of Cincinnati, 2004-2008.

14.  A prospective, randomized, double-blind, placebo controlled study of the effectiveness and safety of Risperdal Consta augmentation in adult patients with frequently-relapsing bipolar disorder.  Janssen Medical Affairs LLC. University of Cincinnati, 2004-2006.

15.  Dose escalating, phase II study to assess the safety and tolerability of RG2417 in the treatment of bipolar I disorder. Repligen, University of Cincinnati, 2006-2007.

16.   A six-week, double-blind, multicenter, placebo controlled study evaluating the efficacy and safety of flexible doses of oral ziprasidone as add-on, adjunctive therapy with lithium, valproate or lamotrigine in bipolar I depression.  Pfizer Pharmaceuticals, University of Cincinnati, 2008.

17. A long-term open-label phase II randomized, double-blind, placebo-controlled, flexible-dose study of to assess the safety and tolerability of cariprazine in patients with bipolar I disorder.  Forest Pharmaceuticals, University of Cincinnati, 2010-

18.  A randomized, double-blind, placebo-controlled, flexible-dose, parallel-group study of Lurasidonelurasidone adjunctive to lithium or divalproex for the treatment of bipolar I depression.  Lurasidone.  Protocol No. D105256, University of Cincinnati, 2009-

19.  A flexible-dose, open-label extension study of Lurasidone for the treatment of bipolar I depression.  Protocol NO. D105256 Dainippon Sumitomo Pharma America, University of Cincinnati, 2009-

20.  A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolesenets with generalized anxiety disorder.  HMGI-1572, Lily, University of Cincinnati, 2011-2013.

21.   A 52-week, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of an intramuscular depot formulation of aripiprazole (OPC-14597) as maintenance treatment in patients with bipolar I disorder. Otsuka, University of Cincinnati, 2013-

22.  Duloxetine versus placebo in the treatment of elderly patients with generalized anxiety disorder.  Lilly F1J-MC-HMGF, University of Cincinnati, 2011-2012.

23.  A phase 2, randomized, double-blind, placebo-controlled, multicenter study to assess the safety and tolerability of SPD503 in subjects aged 6-17 years with generalized anxiety disorder (GAD), separation anxiety disorder (SAD), or social phobia (SoP).  Shire SPD503-210, University of Cincinnati, 2012-2013.

24.  A phase 4, randomized, double-blind, multicenter, parallel-group, active-controlled, dose optimization safety and efficacy study of SPD489 (Vyvanse®) compared with OROS-MPH (Concerta®) with a placebo reference arm, in adolescents aged 13-17 years with attention-deficit/hyperactivity disorder.  Shire SPD489-408 (ADHD), University of Cincinnati, 2012-2014.

25.  A phase 4, randomized, double-blind, multicenter, parallel-group, active-controlled, forced-dose titration, safety and efficacy study of SPD489 (Vyvanse®) compared with OROS-MPH (Concerta®) with a placebo reference arm, in adolescents aged 13-17 years with ADHD.  Shire SPD489-406, University of Cincinnati, 2012-2014.

26.  A double-blind, placebo-controlled trial of asenapine in the prevention of recurrence of a mood episode after stabilization of an acute manic/mixed episode in subjects with bipolar I disorder.  Merck P06384 (Phase 3B), University of Cincinnati, 2012-

27.  Asenapine for bipolar depression.  Merck IIT, University of Cincinnati, 2013-

28.  A 52-week, multicenter, open-label study to evaluate the effectiveness of an intramuscular depot formulation of aripiprazole (OPC-14597) as maintenance treatment in patients with bipolar I disorder.  Otsuka 252, University of Cincinnati, 2013-

29.  A phase 2, randomized, a double-blind, placebo-controlled evaluation of the safety and efficacy of Vilazodone in adolescent patients with major depressive disorder.  Forest VLZ-MD-21, University of Cincinnati, 2013-

30.  A phase III, randomized, double-blind, placebo-controlled, parallel-arm, multi-center study measuring the efficacy and safety of PRC-063 in adult ADHD patients.  Purdue 010.  University of Cincinnati, 2014-2015.

31.  A six-month, open-label, multi-center study of the safety and efficacy of PRC-063 in adults and adolescent with ADHD.  Purdue 012, 2014-

CURRICULUM VITAE

Name:  Melissa P. DelBello, M.D.

Work Address:  Department of Psychiatry

University of Cincinnati College of Medicine

260 Stetson Street, P.O. Box 670559

Cincinnati, Ohio 45267-0559

Telephone: (513) 558-4489

Fax: (513) 558-3399

E-mail: Bu e-Posta adresi istenmeyen posta engelleyicileri tarafından korunuyor. Görüntülemek için JavaScript etkinleştirilmelidir.

Bu e-Posta adresi istenmeyen posta engelleyicileri tarafından korunuyor. Görüntülemek için JavaScript etkinleştirilmelidir.">Place of Birth: New York, New York

Citizenship: United States of America